WO2020082783A1 - 基于数据处理的药品费用控制方法及装置 - Google Patents

基于数据处理的药品费用控制方法及装置 Download PDF

Info

Publication number
WO2020082783A1
WO2020082783A1 PCT/CN2019/094994 CN2019094994W WO2020082783A1 WO 2020082783 A1 WO2020082783 A1 WO 2020082783A1 CN 2019094994 W CN2019094994 W CN 2019094994W WO 2020082783 A1 WO2020082783 A1 WO 2020082783A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
monitored
cost
drugs
prescription
Prior art date
Application number
PCT/CN2019/094994
Other languages
English (en)
French (fr)
Inventor
袁刚
Original Assignee
平安医疗健康管理股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 平安医疗健康管理股份有限公司 filed Critical 平安医疗健康管理股份有限公司
Publication of WO2020082783A1 publication Critical patent/WO2020082783A1/zh

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • G06Q10/063—Operations research, analysis or management
    • G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
    • G06Q40/08—Insurance
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Definitions

  • This application relates to the field of medical technology, and in particular to a method and device for controlling drug expenses based on data processing.
  • Various medication monitoring mechanisms are used to monitor medication for various medical units, including but not limited to medical units (or representatives of medical units) such as various hospitals, departments of various hospitals, various clinics, and even various physicians.
  • the evaluation of the medication standard of each medical unit mainly adopts the sub-average prescription standard, that is, the average cost of prescriptions calculated each time (abbreviated as the sub-average prescription cost) is used as the evaluation standard of each medical unit.
  • the evaluation criteria for the above-mentioned average prescription cost are calculated by dividing the total prescription by the number of prescriptions.
  • the use of sub-average prescription cost as the evaluation standard of each medical unit has led each medical unit to be evaluated in order to avoid large prescriptions.
  • the number of prescription days is reduced to reduce the average prescription cost, or a single prescription is broken down by breaking down the prescription.
  • the embodiments of the present application provide a method and device for controlling drug costs based on data processing.
  • the operation is simple, which can improve the accuracy of drug monitoring of medical units, improve the reliability of drug monitoring of medical units, and improve the effective utilization of medical resources. Rate, the applicability is stronger.
  • an embodiment of the present application provides a method for controlling drug expenses based on data processing.
  • the method includes:
  • the medical cost over-alarm warning information will be sent to the medical unit to be monitored based on the above-mentioned drug cost over-alarm warning The information prompts the above-mentioned medical units to be monitored for drug cost control.
  • an embodiment of the present application provides a medical expense control device based on data processing.
  • the medication monitoring device includes:
  • the data obtaining unit is used to obtain the medicine prescription of the medical unit to be monitored and obtain the medicine information included in the above medicine prescription;
  • a drug information processing unit configured to determine the average daily drug cost of the medical unit to be monitored based on the drug information acquired by the data acquisition unit;
  • the medicine information processing unit is further used to determine the number of patients corresponding to the medicine prescription based on the patient information included in the medicine prescription acquired by the data acquisition unit, and determine the medical unit to be monitored based on the medicine information and the number of patients Of medicines per person per day;
  • the medicine information processing unit is also used to determine the target medicine in the above-mentioned medicine prescription based on the medicine information of various medicines included in the above-mentioned medicine information, and determine the above-mentioned target medicine in the above-mentioned medicine prescription according to the medicine information of the above-mentioned medicines The target drug ratio;
  • the drug cost monitoring unit is used to determine whether the daily average drug cost, the daily drug cost per person, and the target drug ratio determined by the drug information processing unit are greater than the drug index parameter threshold of the medical unit to be monitored;
  • the drug cost control unit is used to notify the medical unit to be monitored when the above-mentioned drug cost monitoring unit determines that the daily average drug cost, the daily drug cost per person, and the target drug ratio are greater than the threshold of the drug index parameter of the medical unit to be monitored Send early warning information of excessive drug cost, and prompt the medical unit to be monitored for drug cost control based on the early warning information of excessive drug cost.
  • an embodiment of the present application provides a terminal device.
  • the terminal device includes a processor, a transceiver, and a memory, and the processor, the transceiver, and the memory are connected to each other.
  • the memory is used to store a computer program that supports the terminal device to execute the method provided in the first aspect and / or any possible implementation manner of the first aspect, the computer program includes program instructions, and the processor and the transceiver are configured to When the above program instructions are invoked, the method provided in the first aspect and / or any possible implementation manner of the first aspect is executed.
  • an embodiment of the present application provides a computer-readable storage medium storing a computer program, the computer program including program instructions, which when executed by a processor causes the processor to execute The method provided in the foregoing first aspect and / or any possible implementation manner of the first aspect.
  • multiple drug index parameters ie, average daily drug cost, daily average drug cost per person, and target drug ratio
  • the timeliness of the control improves the reliability of the medical unit's medication monitoring, improves the effective utilization of medical resources, and is more applicable.
  • FIG. 1 is a schematic flowchart of a method for controlling drug expenses based on data processing provided by an embodiment of the present application
  • FIG. 2 is another schematic flow chart of a method for controlling drug expenses based on data processing provided by an embodiment of the present application
  • FIG. 3 is a schematic structural diagram of an embodiment of a data processing-based medicine cost control device provided by an embodiment of the present application.
  • FIG. 4 is a schematic structural diagram of an embodiment of a terminal device provided by an embodiment of the present application.
  • the embodiments of the present application provide a method for controlling drug costs based on data processing, which can be based on the daily average of medical units (or representatives (or teams) of medical units) of various hospitals, hospital departments, clinics, and physicians
  • the drug cost, the average daily drug cost per person, and the target drug ratio are used to evaluate whether the drug cost of each medical unit (including hospital, department, clinic, or physician) exceeds the standard (or is reasonable).
  • one or more of the multiple drug index parameters of the medical unit to be monitored exceeds the standard, it can be based on one of the average daily drug cost, the average daily drug cost per person and the target drug ratio of the medical unit to be monitored or A number of early warning messages are sent to the medical units to be monitored to warn the medical units to be monitored of the prescribing drugs, prevent the medical costs of the medical units to be monitored from continuing to exceed the standard, and avoid the drugs of the medical units to be monitored, etc. Waste of medical resources.
  • the medical unit's medical expense reimbursement request and / or claim request may be rejected to realize the early warning of the medical unit's excessive medical cost and remind the medical
  • the unit controls the cost of prescription drugs to avoid wasting medical resources.
  • the average daily drug cost per person refers to the average daily drug cost per person, and the following will be described in conjunction with the average daily drug cost.
  • the assessment dimensions represented by the representatives of the above-mentioned hospitals, departments of various hospitals, clinics, and even doctors or other medical units or medical units will be described using the evaluation dimension of the medical unit as an example, and will not be described below.
  • the determination of valuable medicines in various regions is to determine the medicines whose unit price of the smallest packaging unit (such as a bottle, a pack, a box or a bag, etc.) exceeds a certain threshold as valuable medicines.
  • this method does not take into account the number of days of use of the unit price of the smallest packaging unit for the determination of valuable drugs, so the possible drawback is that the same unit price of the drug or a low-priced drug or a high-priced drug is used for different days. Inverted situation with higher unit price but lower average daily price.
  • the price of a single drug box is 300 yuan, which is judged as a valuable drug according to the current method of judging precious drugs in various regions; the box of this valuable drug can be used for 30 days, that is, the average daily price of the drug is 10 yuan / day.
  • the price of another single drug box is 120 yuan, which is judged to be non-precious drug according to the current method of judging precious drugs in various regions; the box of this drug can be used for 3 days, that is, the average daily price of the drug is 40 yuan / day. It can be seen that the average daily price of non-precious drugs judged according to the current method of judging precious drugs in various regions exceeds the average daily price of precious drugs.
  • the target medicine provided by the embodiment of the present application may be a valuable medicine, and the determination method of the valuable medicine here is different from the above-mentioned current determination method of the valuable medicine in each region.
  • the valuable drug may be a drug whose daily average drug cost is high among various types of drugs included in the prescription and is ranked high in the daily average drug cost of various types of drugs included in the prescription.
  • the following will take precious medicines as an example and describe in conjunction with the data processing based warning method for exceeding the warning of medicines provided by the embodiments of the present application.
  • the proportion of target drugs can be explained by taking the proportion of valuable drugs as an example, which will not be repeated below.
  • the medication prescriptions provided in the embodiments of the present application may include prescriptions issued by various doctors of various medical units for the symptoms of various patients, or referred to as prescriptions prescribed by various physicians for the symptoms of various patients, or prescription papers, etc., in There are no restrictions. For the convenience of description, the prescription will be described as an example below. Generally speaking, the prescriptions issued by various doctors in various medical units may include but are not limited to the time of prescription issuance, prescription number, department number, patient information (including patient personal information), drug details and physician signature, which can be based on The actual application scenario is determined, and is not limited here.
  • each prescription will contain the details of the medicine issued by the medical unit, including but It is not limited to the name of the drug, the amount of the drug, the method of using the drug, and the number of days the drug is used. Based on the details of the drugs included in each prescription, it can be determined that the single-drug daily average drug cost is high and the top ranked drugs are valuable drugs, and then the proportion of the total cost of drugs in all prescriptions based on the cost of precious drugs (i.e. expensive Drug ratio) to determine whether the medication is reasonable. Therefore, whether it is a large prescription or a small prescription or other, it is inseparable from the drug details.
  • the medical unit's drug use can be monitored daily, and then the medical unit can be settled daily
  • the daily average drug cost, average daily drug cost per person and the proportion of valuable drugs of the prescriptions of medicines are based on the daily average daily drug cost, daily average drug cost per person and the proportion of valuable drugs to monitor the medical unit's medication situation.
  • the medical unit can be monitored for drug use, and the medical unit can also be comprehensively evaluated based on the cumulative multi-day drug monitoring situation.
  • the daily drug cost per person and the proportion of valuable drugs monitor and / or evaluate the drug use of medical units as an example, and describe the drug cost control method based on data processing provided in the embodiments of the present application.
  • the drug cost control method based on data processing can be executed by terminal devices associated with drug monitoring units such as the Drug Administration, the Health Commission, the Health and Health Commission, and medical claim units.
  • drug monitoring units such as the Drug Administration, the Health Commission, the Health and Health Commission, and medical claim units.
  • the above drug monitoring units are used to Clients and / or human-computer interaction devices that monitor medical use of various medical units are not limited here.
  • the terminal device may be a tool used by the medical unit to be monitored for drug cost control and early warning of excessive drug costs for each doctor's prescribing medication, such as the doctor's prescription Tools, etc., are not restricted here.
  • the terminal device may be a client and / or a human-computer interaction device for monitoring drug use of each medical unit, which is not limited herein.
  • the terminal device will be taken as an example for description below.
  • FIG. 1 is a schematic flowchart of a data processing-based medicine cost control method provided by an embodiment of the present application.
  • the medicine cost control method based on data processing provided by the embodiments of the present application can be described by the implementation manners provided in the steps S11 to S16 as follows.
  • the above-mentioned medical unit to be monitored may be any medical unit monitored by the medication monitoring unit, which may be specifically determined according to actual application scenarios, and is not limited herein.
  • any medical unit may be monitored by the medication monitoring unit, so the selected monitoring object may be the medical unit to be monitored.
  • the medical unit to be monitored will be described as an example below.
  • the medication prescriptions of the above medical units may include all medication prescriptions generated by the medical unit to be monitored within a single day.
  • all medication prescriptions generated by the above-mentioned medical unit to be monitored within a single day can be explained by taking a single-day prescription as an example.
  • the single-day prescription of the above medical unit may refer to all prescriptions issued by the medical unit on any day, including but not limited to all prescriptions issued by all doctors in all departments of the hospital within a single day, and all doctors in a department of the hospital within a single day All prescriptions issued, or any prescriptions issued by a physician in a department of a hospital within a single day.
  • the specific conditions indicated by the above single-day prescriptions are based on the evaluation dimension of the medical unit's medication monitoring in the actual application scenario (for example, the medical unit's medication monitoring, the medical unit's medication monitoring for a medical department, or the medical unit's medication monitoring A certain doctor in a department carries out medication monitoring, etc.), and it is not restricted here.
  • the following will take all prescriptions issued by all doctors in all departments of the hospital within a single day as an example, hereinafter referred to as a single-day prescription. For example, suppose that all the prescriptions issued by all the doctors in a medical unit in a day are S (for example, 80) prescriptions.
  • one of the 80 prescriptions is for one patient, so the 80 prescriptions correspond to the disease
  • the number of patients is 80.
  • the quantity will not be repeated below.
  • the total number of medicines included in each of the above 80 prescriptions is K (for example, the total number of medicines is 200)
  • the average daily medicine cost can be calculated based on the details of each medicine in the 200 medicines.
  • the average daily medicine cost per person of the medical unit can be calculated.
  • the valuable drugs and the proportion of the valuable drugs can be determined from the above 200 drugs, which can be based on the average daily drug cost, average daily drug cost and The proportion of valuable drugs monitors the use of drugs by medical institutions.
  • the above-mentioned single-day prescription of the medical unit to be monitored may be a prescription for real-time warning of excessive drug costs of the medical unit to be monitored, and this part of the prescription may be issued by each doctor within a single day of the medical unit to be monitored All or part of the prescription.
  • the real-time warning of excessive drug cost for the medical unit to be monitored can be the daily average drug cost, the average daily drug cost per person and the proportion of valuable drugs of the medical unit to be monitored come to the critical point where the drug index parameter exceeds the standard (i.e.
  • the average daily drug cost per person is equal to the average daily drug cost threshold and / or the proportion of valuable drugs is equal to the threshold value of precious drugs), and it is used to notify the physician of the medical unit to be monitored in real time.
  • Prescriptions may lead to prescriptions that exceed the standard of drug index parameters such as the average daily drug cost, the average daily drug cost per person, and / or the proportion of valuable drugs of the medical unit to be monitored, so that the physician can determine whether to continue to prescribe.
  • the above-mentioned single-day prescription of the medical unit to be monitored may also be a prescription for early warning of excessive drug costs of the medical unit to be monitored, and this part of the prescription may be all prescriptions issued by various doctors within a single day of the medical unit to be monitored.
  • the early warning of excessive drug cost in the later period may be based on a single-day prescription based on the current assessment cycle (for example, a certain day) of the medical unit to be monitored to determine the daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs, etc.
  • the parameter exceeds the standard that is, the average daily drug cost is greater than the average daily drug cost threshold, the average daily drug cost is greater than the average daily drug cost threshold and / or the proportion of valuable drugs is greater than the value threshold of the valuable drug
  • the drug index parameters such as the daily average drug cost, the average daily drug cost per person, and / or the proportion of valuable drugs exceed the standard
  • the medical unit to be monitored is issued an early warning of the drug cost exceeding the standard, to remind the medical unit to be monitored to pay attention to the daily average in the subsequent evaluation cycle Control of drug index parameters such as drug cost, daily drug cost per person, and / or proportion of valuable drugs to prevent the recurrence of drug cost parameters such as daily average drug cost, daily drug cost per person, and / or proportion of valuable drugs, etc.
  • Penalties such as reimbursement and / or rejection of claims.
  • the specific manifestation of the single-day prescription of the medical unit to be monitored can be determined according to the application scenario (real-time or later) demand of early warning of drug cost exceeding the actual application scenario, and no limitation is made here.
  • the following single-day prescriptions will be described using real-time obtained prescriptions as examples, including but not limited to all or part of the prescriptions issued by various doctors in various departments of the medical unit.
  • the terminal device can be docked with the data system of the medical unit to be monitored to obtain the access qualification of the data system of the medical unit to be monitored, and from the medical system to be monitored based on the data system access qualification of the medical unit to be monitored
  • the unit's data system obtains the prescription of the medical unit to be monitored, for example, the single-day prescription of the medical unit to be monitored.
  • the terminal device may also screen out the medical claim data such as the single-day prescription of the medical unit from the medical claim data.
  • the terminal device can also obtain prescription data such as the single-day prescription of the medical unit to be monitored from the medical records of patients in each medical unit based on big data analysis, and so on.
  • the terminal device may obtain a single-day prescription of the medical unit to be monitored based on any data acquisition path other than the above-mentioned data acquisition method, which may be determined according to actual application scenarios, without limitation.
  • any single prescription of the medical unit to be monitored here can include the details of the drugs prescribed in the prescription, including but not limited to the name of the drug, the amount of the drug, the way of using the drug (or the method of taking the drug, etc.) ) And the number of days the drug is used can be determined according to the actual application scenario, and is not limited here.
  • the drug information of each drug included in all prescriptions of the single-day prescription of the medical unit to be monitored may be determined, wherein the drug information of any drug includes but not Limited to the amount of medicine and days of medicine use.
  • the drug information of each drug included in all prescriptions in the single-day prescription of the medical unit to be monitored the total number of drugs included in the single-day prescription of the medical unit to be monitored, the total amount of drugs, and the total number of days of drug use, etc. can be determined.
  • the drug amount of any of the above drugs is the price of a single drug by multiplying the unit price and quantity of any drug.
  • the above-mentioned total number of medicines represents the total number of medicines used in all prescriptions in a single-day prescription after accumulation.
  • the total amount of the above drugs is based on the unit price and quantity of each drug included in the single-day prescription to obtain the drug amount of the single drug, and then the drug amounts of all the drugs included in the single-day prescription are accumulated to obtain the drugs of all drugs
  • the total price ie the total amount of medicine.
  • the total number of days of use of the above drugs is the cumulative value of the number of days of use of each drug in all drugs in a single-day prescription.
  • the average daily drug cost of the single-day prescription of the medical unit to be monitored represents the average cost of all drugs included in the single-day prescription of the medical unit to be monitored.
  • the average daily drug cost can be explained. Among them, the average daily drug cost of the single-day prescription of the medical unit to be monitored can be calculated based on the following formula (1):
  • Average daily drug cost total drug / total days of drug use.
  • the total amount of medicines in the above formula (1) is the total price of all medicines obtained by accumulating the medicine amounts of all medicines in a single day prescription
  • the total number of days of use of the above medicines is the number of days of use of each medicine in all medicines in a single day prescription Accumulated value.
  • S13 Determine the number of patients corresponding to the medicine prescription according to the patient information included in the medicine prescription, and determine the average daily drug cost per person of the medical unit to be monitored based on the medicine information and the number of patients.
  • the patient information included in the above medication prescription may include the patient's personal information such as the patient's name, patient's ID number, patient's age, and patient's gender, which can be determined according to the actual application scenario.
  • the patient's personal information such as the patient's name, patient's ID number, patient's age, and patient's gender, which can be determined according to the actual application scenario.
  • one medication prescription in the above medication prescription is for one patient, so the number of patients corresponding to the medication prescription can be determined according to the patient information included in the medication prescription.
  • the number of patients is equal to the total number of prescriptions for medication prescriptions.
  • the calculation of the above per capita daily drug cost can meet the following formula (2):
  • the above-mentioned daily drug cost per person can satisfy the following formula (3):
  • simply using the average daily drug cost to monitor the drug use of the medical unit may cause the medical unit to increase the daily drug cost of the single drug to meet the standard by increasing the type of prescription drug, etc. Drug monitoring, but the daily drug cost per person is still over the standard. Therefore, based on the average daily drug cost, calculating the average daily drug cost per person can increase the drug cost monitoring based on the per capita dimension on the basis of the daily average drug cost, so that the medical unit's medication can be better monitored and the operation is more flexible , More applicable.
  • the terminal device can also calculate the daily average drug cost of each type of drug in the single-day prescription of the medical unit.
  • the daily average drug cost of any kind of drugs will be described below as an example.
  • the medicine information of all kinds of medicines included in all medicine prescriptions can be obtained, and the above-mentioned medicine information includes at least the medicine amount and the days of medicine use. Determine the total drug amount of any drug in the above single-day prescription and the total number of days of drug use of any of the above-mentioned drugs according to the drug information of each type of drug in the above single-day prescription.
  • the total number of days of drug use for a class of drugs determines the average daily drug cost per drug for any of the above-mentioned types of drugs to obtain the average daily drug cost for each drug of the above categories.
  • the calculation of the average daily drug cost of any one of the above drugs can meet the following formula (4):
  • the total price of any kind of medicines in the above formula (4) is the total price of a single medicine of all medicines prescribed in a single day (for convenience of description, it is described in any kind).
  • the total number of days of use of any type of drug is the cumulative value of the number of days of use of that type of drugs in all drugs prescribed in a single day.
  • the average daily single-drug drugs of various types of drugs in the single-day prescription of the medical unit to be monitored The cost can be used to determine the valuable drugs in a single-day prescription based on the average daily drug cost of each type of drug.
  • the average daily drug cost of each type of drug can be determined, and the threshold value of the daily average drug cost corresponding to the single-day prescription of the unit to be monitored can be determined, and the Drugs whose average daily drug cost per drug is greater than or equal to the above-mentioned daily average drug cost threshold are determined to be valuable drugs in the single-day prescription of the medical unit to be monitored.
  • the valuable drug refers to a drug whose daily drug cost per drug is higher than the daily drug cost per drug prescribed for a single day and that the daily drug cost per drug is greater than or equal to the threshold of the daily drug cost per drug.
  • the average daily drug cost of various drugs can be sorted in order from high to low, and then the average daily drug cost of single drug
  • the top part (for example, 20%) of the medicines with the lowest average daily drug cost of the single drug is determined as the average daily drug cost threshold for the single drug.
  • the average daily drug cost of each drug in this part (that is, 20%) of the drugs The drug cost is greater than or equal to the single drug daily average drug cost threshold, and then this part (ie 20%) of the drug can be determined as a valuable drug.
  • the average daily drug cost of a single drug is determined to be x yuan / day (that is, the average daily drug cost threshold for a single drug) according to the average daily drug cost of various drugs, for example, 11 yuan / day Of medicines are valuable medicines.
  • x yuan / day that is, the average daily drug cost threshold for a single drug
  • 11 yuan / day Of medicines are valuable medicines.
  • 20% of all medicines included in the single-day prescription of the medical unit to be monitored are medicines with an average daily drug cost of 11 yuan / day or more, and these medicines are valuable medicines.
  • the total amount of drugs of all drugs in the above-mentioned drug prescription and the total amount of valuable drugs of the above-mentioned valuable drugs included in the above-mentioned drug prescription can be determined.
  • the proportion of valuable drugs in the single-day prescription of the medical unit to be monitored can be determined based on the total amount of all the above drugs and the total amount of valuable drugs.
  • the ratio of precious drugs may be the ratio of the total amount of precious drugs in a single-day prescription to the total price of all drugs prescribed in a single day, that is to say, the ratio of precious drugs satisfies the following formula (5):
  • Proportion of valuable drugs total value of valuable drugs / total amount of drugs of all drugs.
  • the total value of valuable drugs is the cumulative value of various types of valuable drugs in a single-day prescription, where the price of each type of valuable drugs is the product of the quantity of such valuable drugs and the unit price of such valuable drugs.
  • the total amount of medicines of all the above-mentioned medicines is the cumulative value of the prices of various medicines in a single-day prescription.
  • S15 Determine whether the above-mentioned average daily drug cost, the above-mentioned average daily drug cost per person, and the above-mentioned target drug ratio are greater than the threshold of the drug index parameter of the medical unit to be monitored.
  • the evaluation thresholds of the drug monitoring standards and / or drug evaluation standards of each medical unit can be preset, such as the daily average drug cost threshold, that is, the average daily drug cost The upper limit of the standard (or the average daily drug cost limit) and so on.
  • the daily average drug cost threshold corresponding to the medical unit to be monitored can be set based on information such as the historical drug record of the medical unit to be monitored or the drug use policy, and then based on the above determined determined drug to be monitored.
  • the average daily drug cost of a medical unit, combined with the threshold of the daily average drug cost corresponding to the medical unit to be monitored, can determine whether the average daily drug cost of the medical unit meets the standard. In other words, whether the average daily drug cost of the medical unit to be monitored is less than or equal to its corresponding daily average drug cost threshold.
  • the average daily drug cost of the medical unit to be monitored is less than or equal to its corresponding daily average drug cost threshold, it can be determined that the average daily drug cost of the medical unit to be monitored is up to the standard. If the average daily drug cost of the medical unit to be monitored is greater than its corresponding daily average drug cost threshold, it can be determined that the average daily drug cost of the medical unit to be monitored is exceeding the standard. At this time, the above average daily drug cost can be the medical unit to be monitored One of the parameters of the over-standard medication index.
  • the evaluation thresholds of the drug monitoring standards and / or drug evaluation standards of each medical unit may also be set in advance, for example, the per capita daily drug cost threshold, that is The upper limit of the daily average drug cost (or the upper limit of daily drug cost per person), etc.
  • the per-capita daily drug cost threshold corresponding to the medical unit to be monitored can be set based on information such as historical drug records or drug use policies of the medical unit to be monitored, and then based on the determined The daily drug cost per person of the monitoring medical unit is combined with the threshold of the daily drug cost per person corresponding to the medical unit to be monitored to determine whether the daily drug cost per person of the medical unit meets the standard. In other words, whether the average daily drug cost of the medical unit to be monitored is less than or equal to its corresponding average daily drug cost threshold.
  • the average daily drug cost per person of the medical unit to be monitored is less than or equal to its corresponding average daily drug cost threshold, then it can be determined that the average daily drug cost of the medical unit to be monitored is up to the standard. If the average daily drug cost per person of the medical unit to be monitored is greater than its corresponding average daily drug cost threshold, then it can be determined that the average daily drug cost of the medical unit to be monitored is exceeding the standard.
  • the evaluation index thresholds of the drug monitoring standards and / or drug evaluation standards of each medical unit may be set in advance, such as the threshold value of the proportion of valuable drugs, that is, the proportion of valuable drugs The upper limit of compliance (or the upper limit of the proportion of valuable drugs), etc.
  • the threshold of the proportion of valuable drugs corresponding to the medical unit to be monitored can be set based on information such as the historical medication records of the medical unit to be monitored or the drug use policy, and then based on the medical treatment to be monitored determined above
  • the unit s proportion of valuable drugs, combined with the threshold of the proportion of valuable drugs corresponding to the medical unit to be monitored, determines whether the proportion of precious drugs of the medical unit is up to standard. In other words, it is whether the proportion of valuable drugs in the medical unit to be monitored is less than or equal to its corresponding threshold value of the proportion of valuable drugs.
  • the proportion of valuable drugs of the medical unit to be monitored is less than or equal to the corresponding threshold value of the proportion of valuable drugs, it can be determined that the proportion of valuable drugs of the medical unit to be monitored is up to the standard. If the proportion of valuable drugs in the medical unit to be monitored is greater than the corresponding threshold value of the proportion of precious drugs, it can be determined that the proportion of valuable drugs in the medical unit to be monitored is exceeding the standard.
  • the medical unit to be monitored when used for drug monitoring, it can be integrated based on multiple drug index parameters such as the average daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs of the medical unit to be monitored Evaluation. If the above-mentioned medical unit to be monitored has a daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs and other drug index parameters are all up to the standard, it can be determined that the medical cost of the medical unit to be monitored does not exceed the standard.
  • the multiple drug index parameters such as the average daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs of the above-mentioned medical unit to be monitored exceed the standard. For example, if the above-mentioned average daily drug cost is less than or equal to the above-mentioned average daily drug cost threshold, the above-mentioned average daily drug cost per person is less than or equal to the above average daily drug cost threshold, and the ratio of the above-mentioned valuable drug is less than or equal to the above-mentioned threshold value of precious drug ratio Make sure that the above-mentioned medical unit to be monitored does not exceed the drug cost.
  • the above-mentioned average daily drug cost per person is less than or equal to the above-mentioned average daily drug cost threshold, and the proportion of the above-mentioned valuable drug is less than or equal to the above-mentioned threshold value ratio
  • the above-mentioned average daily drug cost, the above-mentioned average daily drug cost per person, and the above-mentioned target drug ratio are greater than the threshold of the drug index parameter of the medical unit to be monitored. In other words, at this time, it can be determined that the drug cost of the medical unit to be monitored exceeds or is close to the standard.
  • a drug cost control scenario where real-time drug cost overrun warning is conducted for the medical unit to be monitored, if it is determined that the medical cost of the medical unit to be monitored exceeds the standard based on the prescription that the medical unit to be monitored has already issued in the current assessment cycle . That is, when the medication index parameters such as the average daily drug cost, the average daily drug cost per person, and the target drug ratio of the medical unit to be monitored are greater than the corresponding threshold of the drug index parameter, when the terminal device obtains the At the request of the prescribing party, it can output an early warning sign of excessive drug cost to the homepage of the doctor's prescribing tool of the medical unit to be monitored.
  • the terminal device can output a warning sign of excessive warning of drug costs on the home page of the prescribing tool of the doctor (such as the user operation interface of the prescribing tool) (for example, the red exclamation mark, etc.) or the warning information such as the early warning of the drug cost exceeding the standard.
  • a warning sign of excessive warning of drug costs on the home page of the prescribing tool of the doctor (such as the user operation interface of the prescribing tool) (for example, the red exclamation mark, etc.) or the warning information such as the early warning of the drug cost exceeding the standard.
  • the doctors of the medical unit to be monitored are reminded that the average daily drug cost of the prescription of the medical unit to be monitored has reached the upper limit of the standard (that is, the day of the prescription of the medical unit to be monitored within the current evaluation cycle
  • the average drug cost is greater than or equal to the daily average drug cost threshold
  • the physician of the medical unit to be monitored can be controlled to prescribe medication to prevent the drug cost from exceeding the standard, so that the early warning of the drug cost of the medical unit to be monitored can be exceeded.
  • a drug cost control scenario for early warning of excessive drug cost of the medical unit to be monitored when the drug cost of the medical unit to be monitored exceeds the standard, according to the above average daily drug cost, the above The average daily drug cost per person, the above target drug ratio and the above drug index parameter thresholds (including the daily average drug cost threshold, per capita daily drug cost threshold and target drug ratio threshold) determine the drugs of the above-mentioned medical unit to be monitored within the current assessment cycle The cost exceeds the standard data.
  • the medical unit to be monitored is sent warning information of excessive drug cost, and the medical unit to be monitored is prompted to conduct prescribing medication cost control within one or more evaluation cycles after the current evaluation cycle based on the drug cost exceeding standard warning information. .
  • the average daily drug cost of a medical unit is greater than the daily average drug cost threshold, it can be determined that the daily average drug cost difference of the above-mentioned medical unit to be monitored exceeds the daily average drug cost threshold (that is, the drug cost exceeds the standard data) .
  • the drug cost exceeding warning early warning information is sent to the medical unit to be monitored, and based on the above drug cost exceeding warning early warning information, the medical unit to be monitored is prompted to prescribe drugs within one or more evaluation cycles after the current evaluation cycle Expense control.
  • the above warning information for exceeding the drug cost includes one or more types of information in instant messaging information, emails or notices.
  • the terminal device may publish the above-mentioned average daily drug cost and the above-mentioned average daily drug cost difference, based on the announced average daily drug cost and the above-mentioned average daily drug cost difference, prompt the doctor of the medical unit to be controlled to control the prescription medication Expenses, to avoid the waste of medicine and other medical resources caused by the doctors of the medical unit to be monitored during the prescribing process, and to realize the control of the medical expenses of the medical unit to be monitored.
  • the medical unit ’s daily drug monitoring daily report will be publicized to control the medications of the medical unit to be monitored and its various doctors ’prescriptions, to avoid the waste of medical resources caused by the continuous daily exceeding of the standard drug cost of the drug prescriptions of the medical unit to be monitored, Drug cost control of the medical unit to be monitored.
  • the above-mentioned average daily drug cost and the above-mentioned average daily drug cost difference can also be publicized on the information announcement interface of each department of the medical unit to be monitored, and / or On the homepage of the prescribing tool, publicity, etc., can be determined according to the actual application scenario, without limitation.
  • the comprehensive evaluation of the medication of the medical unit to be monitored can be realized based on multiple medication index parameters, the medication monitoring operation of each medical unit is simple, and the evaluation dimension of the medication monitoring is more comprehensive, which can improve the medical unit.
  • the accuracy of the medication monitoring of the medical device improves the reliability of the medication monitoring of the medical unit, and can improve the accuracy of the early warning of the drug prescription of the medical prescription for the medical prescriptions of the medical prescriptions based on the medical conditions of the medical units.
  • To improve the controllability of the medication prescribed by the medical unit which can increase the effective utilization of medical resources and have greater applicability.
  • FIG. 2 is another schematic flowchart of a data processing-based medicine cost control method provided by an embodiment of the present application.
  • the medicine cost control method based on data processing provided by the embodiments of the present application can realize the monitoring of the medication situation of the medical unit to be monitored in a single assessment period of multiple days, and the method can be implemented by the following steps S21 to S27 Way to explain.
  • the implementation manner of obtaining the medication prescription of the medical unit to be monitored may refer to the implementation manner provided in step S11 in the foregoing embodiment, and details are not described herein again.
  • the medical prescriptions of the medical unit may further include all medical prescriptions generated by the medical unit to be monitored within a single assessment period of multiple days.
  • the above-mentioned single assessment cycle is greater than one day, such as one week, one month, one quarter, or one year, etc., which is not limited here.
  • all medication prescriptions generated by the above-mentioned medical unit to be monitored in a single assessment cycle over multiple days can be illustrated by taking a single assessment cycle prescription as an example.
  • the single assessment cycle prescription of the medical unit may refer to all prescriptions issued in any assessment cycle of the medical unit, including but not limited to all prescriptions issued by all doctors in all departments of the hospital in a single assessment cycle, and a single All the prescriptions issued by all the doctors in a certain department of the hospital during the assessment cycle, or all the prescriptions issued by a certain doctor in a certain department of the hospital in a single assessment cycle.
  • the specific conditions indicated in the above single assessment cycle prescriptions are based on the evaluation dimensions of drug monitoring of medical units in actual application scenarios (for example, drug monitoring for medical units, drug monitoring for a department of the medical unit, or A certain doctor in a certain department conducts medication monitoring, etc.), and it is not restricted here.
  • the following will take all prescriptions issued by all doctors in all departments of the hospital in a single assessment cycle as an example for explanation, hereinafter referred to as a single assessment cycle prescription.
  • any prescription included in the single assessment cycle prescription of the medical unit to be monitored here can include the details of the drugs prescribed in the prescription, including but not limited to the name of the drug, the amount of the drug, the method of use of the drug and the use of the drug
  • the number of days can be determined according to the actual application scenario, without limitation.
  • the average daily drug cost based on the prescription of the medical unit to be monitored may also be processed to obtain the average daily drug cost of the medical unit to be monitored within a specified time period, for example, one week, one The average daily drug cost per month, quarter or year.
  • a specified time period for example, one week, one The average daily drug cost per month, quarter or year.
  • the following can be used as an assessment cycle for a week, taking the average daily drug cost of a week as an example for explanation, referred to as the average daily drug cost for prescriptions in a single assessment cycle.
  • the average daily drug cost for a single assessment cycle prescription can meet the following formula (6):
  • the total amount of periodic drugs can be the total amount of all drugs accumulated from the total amount of all drugs included in all prescriptions in a single assessment cycle, and the total number of days of use of the above-mentioned periodic drugs can be a single assessment cycle The cumulative value of the number of days of use of each drug in all drugs included in the prescription.
  • any single-day medication prescription on any day within a single assessment cycle can be obtained, and any The drug information of each drug included in the single-day medication prescription, where the drug information includes but is not limited to the drug amount and the number of days the drug is used.
  • the daily average daily drug cost of any day of the medical unit to be monitored may refer to the implementation manner corresponding to formula (1) in the foregoing embodiment, and details are not described herein again.
  • the total number of days of drug use in the daily prescription can be determined, and then the waiting period can be determined based on the total number of days of drug use in the daily prescription Monitor the total days of drug use for all drugs included in the single assessment cycle prescription of the medical unit.
  • the total number of days of drug use on any day within a single assessment period of the medical unit to be monitored is the sum of the number of days of drug use of each drug included in any single-day prescription.
  • the cumulative value of the average daily drug cost per day in a single evaluation cycle of the medical unit to be monitored can be determined according to the daily average daily drug cost of each day in the single evaluation cycle.
  • the accumulated value of the average daily drug cost According to the total number of days of drug use in each day of the single assessment cycle, the accumulated value of the total number of days of drug use in the single assessment period of the medical unit to be monitored can be determined.
  • the daily average drug cost of the medical unit to be monitored is determined according to the cumulative value of the above-mentioned average daily daily drug cost and the cumulative value of the above-mentioned total days of drug use.
  • the average daily drug cost of the medical unit to be monitored (that is, the average daily drug cost of the medical unit to be monitored in a single assessment cycle) can satisfy the following formula (7):
  • Average daily drug cost cumulative value of daily average daily drug cost / cumulative value of total days of drug use.
  • the cumulative value of the average daily drug cost in the above formula (7) may be the cumulative average of the daily drug cost of each single-day prescription in the 7 single-day prescriptions within a week Value
  • the cumulative value of the total number of days of drug use in the above formula (7) may be the cumulative value of the total number of days of drug use in each of the 7 single-day prescriptions within a week.
  • the foregoing implementation method for determining the number of patients corresponding to the medication prescription based on the patient information included in the medication prescription of the medical unit to be monitored, and determining the medical to be monitored based on the drug information included in the medication prescription For a specific implementation manner of the unit's daily drug cost per person, refer to the implementation manner provided in step S13 in the foregoing embodiment, and details are not described herein again.
  • the total number of drugs in all the above-mentioned drug prescriptions is the cumulative value of the drugs included in the drug prescriptions of each day in the single evaluation cycle of the above multiple days, which may be simply referred to as the total number of drugs for convenience of description .
  • the number of patients mentioned above is equal to the total number of prescriptions for all prescriptions in the single assessment cycle for the above multiple days.
  • the calculation of the above per capita daily drug cost can meet the following formula (8):
  • step S14 for the specific implementation manner of determining the average daily drug cost of a single medicine for various types of medicines of the medical unit to be monitored based on the drug information included in the medical prescription of the medical unit to be monitored, see step S14 in the above embodiment The implementation provided will not be repeated here.
  • the terminal device can also calculate each type of drug in all prescriptions within a single assessment cycle of the medical unit over multiple days The average daily drug cost of a single drug. Based on all the prescriptions within a single assessment cycle of the medical unit to be monitored, the drug information of all types of drugs included in all prescriptions can be obtained.
  • the above drug information includes at least the drug amount and the number of days the drug is used.
  • the total amount of medicines of any kind of medicines and the total number of days of use of medicines of any kind of medicines in all prescriptions in the above single assessment period determine the total amount of drugs for a class of drugs and the total number of days of use of any of the above-mentioned drugs determine the average daily drug cost per drug for any of the above-mentioned drugs to obtain the average daily drug cost for each drug of the above-mentioned types.
  • the calculation of the average daily drug cost of a single drug of any of the above drugs can meet the following formula (10):
  • the average daily drug cost of a single drug the total amount of drugs of any type of drug in a single evaluation period / the total number of days of use of drugs of any type of drug in a single evaluation period.
  • the total amount of any kind of medicine in the above formula (10) is the single-medicine medicine obtained by accumulating the price of a certain kind of medicines (for any description in order to facilitate description) of all medicines in a single assessment cycle
  • the total price, the total number of days of use of any type of drug in the above single evaluation cycle is the cumulative value of the number of days of use of the drugs of this type among all prescriptions of all drugs within a single evaluation cycle.
  • each prescription in all prescriptions within a single assessment cycle of the medical unit to be monitored can be determined
  • the average daily drug cost of a single drug of a class of drugs, and then based on the average daily drug cost of a single drug of the above-mentioned types of drugs, can determine the precious drugs in all prescriptions within a single evaluation cycle.
  • the ratio of valuable drugs can be the ratio of the total amount of valuable drugs in all prescriptions in a single evaluation period to the total price of all drugs in all prescriptions in a single evaluation period, that is to say, the ratio of precious drugs satisfies the following formula (11 ):
  • Proportion of valuable drugs total value of valuable drugs / total amount of drugs of all drugs.
  • the total value of valuable drugs is the cumulative value of the prices of various types of valuable drugs in all prescriptions within a single assessment period, where the price of each type of valuable drugs is the number of such valuable drugs and the value of such valuable drugs The product of unit prices.
  • the total amount of medicines of all the above-mentioned medicines is the cumulative value of the prices of all kinds of medicines in all prescriptions in a single assessment period.
  • the specific implementation manner of determining whether the medical cost of the medical unit to be monitored exceeds the standard according to the daily average medical cost of the medical unit to be monitored, the daily drug cost per person, and the target drug ratio described above can be found in the above embodiment
  • the implementation manner provided in step S15 in FIG. 1 will not be described here.
  • the evaluation index thresholds of the drug monitoring standards and / or drug evaluation standards of each medical unit may also be determined based on the unit attribute information of each medical unit,
  • the thresholds for the assessment indicators may include daily drug cost thresholds, per capita daily drug cost thresholds, and valuable drug proportion thresholds, etc., such as upper limit of daily drug cost.
  • the upper limit of the above-mentioned multiple medication indexes will be explained by taking the upper limit of the daily average drug cost as an example, that is, the daily average drug cost threshold.
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the region where the unit is located, the city where the unit is located, the unit drug supply channel, and the number of patients of the unit, which can be determined according to the actual application scenario.
  • the threshold for the assessment index of drug monitoring may be different, that is, the daily average drug cost thresholds corresponding to different medical units may be different.
  • the upper limit of the daily drug cost can be set higher.
  • the corresponding daily average drug cost threshold can be set to a higher threshold.
  • the upper limit of the average daily drug cost can be set lower.
  • the corresponding daily average drug cost threshold can be set to a lower threshold.
  • the specifics can be determined according to actual application scenarios, and no limitation is made here.
  • the setting of the threshold of the average daily drug cost and the threshold of the proportion of valuable drugs corresponding to the medical unit to be monitored can also be set in the same way as the threshold of the daily average drug cost, which can be determined according to the actual application scenario, without limitation .
  • a comprehensive evaluation can be performed based on multiple drug index parameters such as the average daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs of the medical unit to be monitored. If one or more of the three medication index parameters of the above-mentioned medical unit to be monitored, the average daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs are greater than their corresponding thresholds for the medication index parameter, then it can be determined to be monitored. The drug cost of the medical unit exceeds the standard, otherwise it is determined that the drug cost of the medical unit to be monitored does not exceed the standard. For details, refer to the implementation manner provided in step S15 in the foregoing embodiment, and details are not described herein again.
  • two or more drug index parameters in the multiple daily drug index parameters such as the above-mentioned average daily drug cost, daily average drug cost per person, and proportion of valuable drugs exceed the standard.
  • the drug index parameter value can be determined from the above multiple drug index parameters The largest maximum medication index parameter. For example, if there are two or more drug index parameters in the multiple drug index parameters such as the average daily drug cost, the average daily drug cost per person, and the proportion of valuable drugs of the medical unit to be monitored, the average daily drug cost is X1 Yuan, the average daily drug cost per person is X2 yuan, and the cost of expensive drugs corresponding to the proportion of expensive drugs is X3 yuan.
  • the daily medication cost is the largest among the three medication index parameters of the above average daily drug cost, average daily drug cost per person and proportion of valuable drugs.
  • the largest one is the average daily drug cost, which can be determined based on big data analysis
  • the reason why the average daily drug cost exceeds the standard for example, the cost of a certain drug (for convenience of description can be described as an example), and then the cost of the drug exceeding the standard can be used as the control cost of the drug cost of the medical unit to be monitored standard.
  • the X1 yuan can be used as the basis for the drug cost of the medical unit to be monitored, and the drug costs associated with the over-standard drugs included in the X2 yuan can be excluded to obtain the person who does not include the drug cost of the over-standard drugs.
  • Average daily drug cost X2 ' In the same way, the cost of medicines associated with the above-standard medicines included in the above X3 yuan can be removed to obtain the cost of expensive medicines X3 'that does not include the cost of medicines of the above-mentioned medicines. Determine the proportion of valuable drugs after excluding excessive drugs.
  • the drug index parameters such as the daily drug cost per person or the proportion of valuable drugs excluding the over-standard drugs exceed the standard, or Except for the above-mentioned drug costs for drugs that exceed the standard, the cumulative calculation of drug costs corresponding to multiple drug index parameters such as the average daily drug cost or the proportion of valuable drugs, etc., exceeds the standard.
  • the daily drug cost per person or the proportion of valuable drugs excluding the drug cost of the above-mentioned drug exceeds the standard drug index parameter of less than one in the multiple drug index parameters, or the above-mentioned drug cost excluding the drug cost of the standard drug per person Or the cumulative calculation of drug costs corresponding to multiple drug index parameters such as the proportion of valuable drugs does not exceed the standard, it can be determined that the drug cost of the medical unit is up to the standard.
  • the specifics can be determined according to actual application scenarios, and no limitation is made here.
  • the medical unit to be monitored is sent a warning message of the drug cost exceeding the standard, based on the above warning.
  • an out-of-standard warning sign for drug cost is output to the homepage of the doctor ’s prescription tool of the medical unit to be monitored
  • the physician of the medical unit issues an early warning of exceeding the drug cost, and publicizes the difference between the drug costs of the above-mentioned medical unit to be monitored, so as to realize the early warning of exceeding the medical cost of the medical unit to be monitored, see step S16 in the above embodiment The implementation provided will not be repeated here.
  • the to-be-monitored data may also be received
  • a medical unit submits a medical expense reimbursement request or a pharmaceutical cost claim request
  • it can achieve a drug cost overrun within the current assessment period for the medical unit to be monitored by rejecting the medical cost reimbursement request or the pharmaceutical cost claim request of the medical unit to be monitored Punishment of this assessment standard in order to provide early warning of the medical unit's follow-up assessment cycle of drug costs exceeding the standard.
  • the medical unit ’s average daily drug cost exceeds a certain day when receiving the medical unit ’s reimbursement and / or request for the day ’s drug cost, the medical unit may be fed back the medical cost of all prescriptions for that day Reimbursement failed.
  • the terminal device can feed back the medical unit's day when receiving the prescription drug cost reimbursement and / or claim request from the medical unit for that day Refusal to reimburse or settle claims for prescription drug costs, and may prompt the medical unit to self-control the daily daily drug cost of daily prescriptions to prevent the daily average drug cost from exceeding the standard for one or more days in order to achieve the drug cost of the medical unit.
  • the terminal device may calculate the medical unit to be monitored The difference between the daily average drug cost and the above-mentioned daily average drug cost threshold (ie, the drug cost exceeds the standard data).
  • the terminal device may respond to the difference between the daily average medical cost of the medical unit to be monitored and the above-mentioned daily average medical cost threshold per person.
  • the part of the drug cost of the single-day prescription of the medical unit to be monitored refuses to be reimbursed or settled for early warning of drug cost exceeding the standard for the subsequent evaluation cycle of the medical unit.
  • the terminal device determines that the prescribed medication within a certain evaluation cycle of the medical unit to be monitored (that is, the current evaluation cycle, such as one day or one week, etc.) exceeds the standard, for example, a certain medical unit to be monitored
  • the terminal device can be in the evaluation cycle (the daily average drug cost of a single-day prescription exceeds a certain day, such as Monday)
  • the daily average drug cost of the assessment cycle is reported via instant messaging, email, and / or notice One or more types of information are sent to the medical unit to be monitored.
  • the daily average drug cost exceeding report is used to remind the medical unit to be monitored that the drug cost exceeds the standard within the evaluation period, and can remind the medical unit to be monitored if it is within the next evaluation period or multiple consecutive evaluation periods within the specified time If the average daily drug cost still exceeds the standard, the medical unit to be monitored will be given a warning that the average daily drug cost exceeds the standard.
  • the above-mentioned punishment includes the refusal to reimburse or settle all the daily average medical expenses for the medical unit to be monitored, or the refusal to reimburse or claim the excessive daily medical expenses of the medical unit to be monitored.
  • the above-mentioned daily average drug cost over-standard report is used to prompt the medical unit to be monitored to control the daily average drug cost in order to realize the drug cost control of the medical unit to be monitored.
  • the medical drug monitoring operation modes of various medical units are various, which can not only improve the accuracy of medical drug monitoring of medical units, but also improve the reliability of medical drug monitoring of medical units, and can also enhance the medical treatment of medical units.
  • the operational flexibility of the unit's medication monitoring can further improve the publicity of early warning of drug cost overruns for prescriptions of various medical units based on the drug use status of each medical unit, and / or rejection of drug cost reimbursement and / or claims for claims corresponding to drug overruns
  • the reliability of early warning of drug costs exceeding the standard can improve the timeliness of early warning of drug costs exceeding the standard of the medical unit to be monitored, thereby improving the effective utilization of medical resources and having greater applicability.
  • FIG. 3 is a schematic structural diagram of an embodiment of a data processing-based medicine cost control device provided by an embodiment of the present application.
  • the medicine cost control device based on data processing provided by the embodiments of the present application includes:
  • the data acquiring unit 31 is used to acquire the medication prescription of the medical unit to be monitored, and acquire the medicine information included in the medication prescription.
  • the medicine information processing unit 32 is configured to determine the average daily medicine cost of the medical unit to be monitored based on the medicine information acquired by the data acquisition unit 31.
  • the medicine information processing unit 32 is further configured to determine the number of patients corresponding to the medicine prescription according to the patient information included in the medicine prescription acquired by the data acquisition unit 31, and determine the to-be-monitored based on the medicine information and the number of patients The average daily drug cost per person in a medical unit.
  • the medicine information processing unit 32 is further used to determine the target medicine in the medicine prescription based on the medicine information of the medicines included in the medicine information, and determine the target medicine in the medicine prescription according to the medicine information of the medicines The target drug proportion in.
  • the drug cost monitoring unit 33 is used to determine whether the daily average drug cost, the daily drug cost per person, and the target drug ratio determined by the drug information processing unit 32 are greater than the drug index parameter threshold of the medical unit to be monitored.
  • the drug cost control unit 34 is used to notify the above-mentioned to-be-monitored when the above-mentioned drug-cost monitoring unit 33 determines that the above-mentioned average daily drug cost, the above-mentioned daily average drug cost per person, and the above-mentioned target drug ratio are greater than the threshold of the drug index parameter of the medical unit to be monitored
  • the medical unit sends an early warning message that the drug cost exceeds the standard, and prompts the medical unit to be monitored to control the drug cost based on the early warning message that the drug cost exceeds the standard.
  • the above warning information for exceeding the drug cost includes the warning label for exceeding the drug cost
  • the above-mentioned drug cost control unit 34 is used to:
  • the above medication prescription includes all medication prescriptions of the medical unit to be monitored within the current assessment period;
  • the above-mentioned drug cost control unit 34 is used to:
  • the above-mentioned average daily drug cost per person, the above-mentioned target drug ratio and the above-mentioned drug index parameter threshold determine the data of over-standard drug cost of the medical unit to be monitored in the current assessment cycle
  • the drug cost exceeding warning early warning information is sent to the medical unit to be monitored, and based on the above drug cost exceeding warning early warning information, the medical unit to be monitored is prompted to prescribe medication within one or more evaluation cycles after the current evaluation cycle Drug cost control;
  • the above warning information for exceeding the drug cost includes one or more types of information in instant messaging information, emails or notices.
  • the data acquisition unit 31 is used to:
  • the medication prescription of the medical unit to be monitored includes all prescriptions of the medication of the medical unit to be monitored in a single assessment cycle, and the single assessment cycle includes a single day or multiple days.
  • the medication prescriptions of the medical unit to be monitored include all medication prescriptions of the medical unit to be monitored within a single day;
  • the above drug information processing unit 32 is used to:
  • the above drug information includes at least the drug amount and the number of days the drug is used;
  • the drug prescriptions of the medical unit to be monitored include all drug prescriptions of the medical unit to be monitored in a single assessment period of multiple days;
  • the above drug information processing unit 32 is used to:
  • the above-mentioned drug information includes at least the drug amount and the number of days of drug use;
  • the total number of days of drug use for any one day is the sum of the number of days of drug use for each drug included in any one-day medication prescription.
  • the above-mentioned drug information processing unit 32 is used to:
  • the daily average drug cost of the medical unit to be monitored is determined according to the cumulative value of the above-mentioned daily average daily drug cost and the cumulative value of the above-mentioned total days of drug use.
  • Daily average drug cost cumulative value of daily average daily drug cost / cumulative value of total days of drug use.
  • the daily medical expenses of the medical unit to be monitored meet:
  • Average daily drug cost total periodical drugs / total days of periodical drugs
  • the total amount of medicines in the above period may be the total amount of all medicines obtained by accumulating the amount of all prescription medicines in a single assessment period, and the total number of days of use of the above period medicines may be each medicine in all medicines in a single assessment period The cumulative value of the number of days of medicine used.
  • the above-mentioned drug information processing unit 32 is used to:
  • the number of patients mentioned above is determined as the number of patients corresponding to the above prescription.
  • the above-mentioned drug information processing unit 32 is used to:
  • Average daily drug cost total drug / total days of drug use
  • Daily drug cost per person total number of drugs / number of patients * average daily drug cost.
  • the above-mentioned drug information processing unit 32 is used to:
  • the drug information of the above-mentioned types of drugs includes at least the amount of drugs and the number of days of use of the drugs;
  • the drug information of the above-mentioned types of drugs determine the total amount of drugs of any type of drugs in the above-mentioned prescriptions and the total number of days of drug use of any of the above types of drugs;
  • the medicine with a threshold is determined as the target medicine in the above medicine prescription.
  • the average daily drug cost of any of the above-mentioned drugs meets:
  • the average daily drug cost of a single drug the total drug amount of any type of drug / the total number of days of drug use of any type of drug.
  • the above-mentioned drug information processing unit 32 is used to:
  • the above target drug ratio meets:
  • Target drug ratio total target drug / total drug for all drugs.
  • the thresholds of the drug index parameters include a daily average drug cost threshold and / or a daily average drug cost threshold and / or a target drug proportion threshold;
  • the above drug cost monitoring unit 33 is used for:
  • the unit attribute information of the medical unit to be monitored determine the daily average drug cost threshold and / or daily average drug cost threshold and / or target drug proportion threshold of the medical unit to be monitored;
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the area where the unit is located, the city where the unit is located, the unit drug supply channel, and the number of unit patients.
  • the above-mentioned data processing-based medicine cost control device may execute the implementation manners provided by the above steps in FIGS. 1 to 2 through various built-in functional modules.
  • the above-mentioned data processing-based medicine cost control device may be the terminal device described in each of the above embodiments, which is not limited herein.
  • the medication monitoring device based on the medication monitoring device can implement various medication monitoring operation modes for each medical unit, which can not only improve the accuracy of the medication monitoring of the medical unit, but also improve the reliability of the medication monitoring of the medical unit. It can enhance the operational flexibility of the medical unit's medication monitoring, and thus can increase the publicity of the drug cost of the medical unit's prescription based on the medical condition of each medical unit, and / or reject the drug cost reimbursement and corresponding to the drug index exceeding the standard.
  • the reliability of the risk control of excessive drug use such as claims or claims can improve the controllability of the medication prescribed by the medical unit, which can increase the effective utilization of medical resources and have greater applicability.
  • FIG. 4 is a schematic structural diagram of an embodiment of a terminal device provided by an embodiment of the present application.
  • the terminal device in this embodiment may include: one or more processors 401, a memory 402, and one or more transceivers 403.
  • the processor 401, the memory 402, and the transceiver 403 are connected through a bus 404.
  • the memory 402 is used to store a computer program, and the computer program includes program instructions.
  • the processor 401 and the transceiver 403 are used to execute the program instructions stored in the memory 402.
  • the processor 401 is configured to call the program instruction to perform the following operations:
  • the transceiver 403 is configured to determine that the average daily drug cost, the average daily drug cost per person, and the target drug ratio are greater than the threshold of the drug index parameter of the medical unit to be monitored by the processor 402, and then send to the medical unit to be monitored.
  • the early warning information of excessive drug cost based on the early warning information of excessive drug cost, prompts the medical unit to be monitored to control the drug cost.
  • the above warning information for exceeding the drug cost includes the warning label for exceeding the drug cost
  • the above transceiver 403 is used to:
  • the above medication prescription includes all medication prescriptions of the medical unit to be monitored within the current assessment period;
  • the above transceiver 403 is used to:
  • the above-mentioned average daily drug cost per person, the above-mentioned target drug ratio and the above-mentioned drug index parameter threshold determine the data of over-standard drug cost of the medical unit to be monitored in the current assessment cycle
  • the drug cost exceeding warning early warning information is sent to the medical unit to be monitored, and based on the above drug cost exceeding warning early warning information, the medical unit to be monitored is prompted to prescribe medication within one or more evaluation cycles after the current evaluation cycle Drug cost control;
  • the above warning information for exceeding the drug cost includes one or more types of information in instant messaging information, emails or notices.
  • the foregoing processor 401 is configured to:
  • the medication prescription of the medical unit to be monitored includes all prescriptions of the medication of the medical unit to be monitored in a single assessment cycle, and the single assessment cycle includes a single day or multiple days.
  • the medication prescription of the medical unit to be monitored includes the prescription of all useful medicines of the medical unit to be monitored within a single day;
  • the above processor 401 is used to:
  • the above drug information includes at least the drug amount and the number of days the drug is used;
  • the drug prescriptions of the medical unit to be monitored include all drug prescriptions of the medical unit to be monitored in a single assessment period of multiple days;
  • the above processor 401 is used to:
  • the above-mentioned drug information includes at least the drug amount and the number of days of drug use;
  • the total number of days of drug use for any one day is the sum of the number of days of drug use for each drug included in any one-day medication prescription.
  • the foregoing processor 401 is configured to:
  • the daily average drug cost of the medical unit to be monitored is determined according to the cumulative value of the above-mentioned daily average daily drug cost and the cumulative value of the above-mentioned total days of drug use.
  • Daily average drug cost cumulative value of daily average daily drug cost / cumulative value of total days of drug use.
  • the daily medical expenses of the medical unit to be monitored meet:
  • Average daily drug cost total periodical drugs / total days of periodical drugs
  • the total amount of medicines in the above period may be the total amount of all medicines obtained by accumulating the amount of all prescription medicines in a single assessment period, and the total number of days of use of the above period medicines may be each medicine in all medicines in a single assessment period The cumulative value of the number of days of medicine used.
  • the foregoing processor 401 is configured to:
  • the number of patients mentioned above is determined as the number of patients corresponding to the above prescription.
  • the foregoing processor 401 is configured to:
  • Average daily drug cost total drug / total days of drug use
  • Daily drug cost per person total number of drugs / number of patients * average daily drug cost.
  • the foregoing processor 401 is configured to:
  • the drug information of the above-mentioned types of drugs includes at least the amount of drugs and the number of days of use of the drugs;
  • the drug information of the above-mentioned types of drugs determine the total amount of drugs of any type of drugs in the above-mentioned prescriptions and the total number of days of drug use of any of the above types of drugs;
  • the medicine with a threshold is determined as the target medicine in the above medicine prescription.
  • the average daily drug cost of any of the above-mentioned drugs meets:
  • the average daily drug cost of a single drug the total drug amount of any type of drug / the total number of days of drug use of any type of drug.
  • the foregoing processor 401 is configured to:
  • the above target drug ratio meets:
  • Target drug ratio total target drug / total drug for all drugs.
  • the thresholds of the drug index parameters include a daily average drug cost threshold and / or a daily average drug cost threshold and / or a target drug proportion threshold;
  • the above processor 401 is used to:
  • the unit attribute information of the medical unit to be monitored determine the daily average drug cost threshold and / or daily average drug cost threshold and / or target drug proportion threshold of the medical unit to be monitored;
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the region where the unit is located, the city where the unit is located, the drug supply channel of the unit, and the number of patients of the unit.
  • the processor 401 may be a central processing unit (CPU), and the processor may also be other general-purpose processors, digital signal processors (DSPs), and dedicated integrations. Circuit (application specific integrated circuit, ASIC), ready-made programmable gate array (field-programmable gate array, FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc.
  • the general-purpose processor may be a microprocessor or the processor may be any conventional processor or the like.
  • the memory 402 may include a read-only memory and a random access memory, and provide instructions and data to the processor 401 and the transceiver 403. A portion of the memory 402 may also include non-volatile random access memory. For example, the memory 402 may also store device type information.
  • the above-mentioned terminal device may execute the implementation manners provided by the above steps in FIG. 1 to FIG. 2 through the respective functional modules of the built-in processor 401 and the transceiver 403. For details, see the above steps The implementation provided will not be repeated here.
  • various operation modes of drug monitoring of medical units can be realized, which can not only improve the accuracy of drug monitoring of medical units, but also improve the reliability of drug monitoring of medical units, and can also be enhanced Operational flexibility for monitoring medication in medical units.
  • the reliability of early warning of drug cost overruns and / or rejection of drug cost reimbursements and / or claims for medical expenses corresponding to drug overruns by terminal equipment based on the drug use of each medical unit can be improved. It can improve the timeliness of early warning of the medical expenses of the medical units to be monitored, so that the effective utilization of medical resources can be improved and the applicability is stronger.
  • Embodiments of the present application also provide a computer-readable storage medium that stores a computer program, and the computer program includes program instructions, which are executed by a processor to implement the steps in FIGS. 1 to 2.
  • the computer program includes program instructions, which are executed by a processor to implement the steps in FIGS. 1 to 2.
  • the above-mentioned computer-readable storage medium may be the medical expense control device based on data processing provided in any of the foregoing embodiments or the internal storage unit of the above-mentioned terminal device, such as a hard disk or memory of an electronic device.
  • the computer-readable storage medium may also be an external storage device of the electronic device, such as a plug-in hard disk equipped on the electronic device, a smart memory card (smart media card, SMC), a secure digital (SD) card, Flash card (flash card), etc.

Landscapes

  • Business, Economics & Management (AREA)
  • Engineering & Computer Science (AREA)
  • General Business, Economics & Management (AREA)
  • Human Resources & Organizations (AREA)
  • Health & Medical Sciences (AREA)
  • Development Economics (AREA)
  • Economics (AREA)
  • Strategic Management (AREA)
  • Public Health (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Marketing (AREA)
  • Accounting & Taxation (AREA)
  • Educational Administration (AREA)
  • Finance (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Technology Law (AREA)
  • Game Theory and Decision Science (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)
  • Tourism & Hospitality (AREA)
  • Biomedical Technology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

一种基于数据处理的药品费用控制方法及装置，该方法包括：获取用药处方和用药处方中所包括的药品信息，并根据药品信息确定日均药品费用；根据用药处方中包括的病患信息确定用药处方所对应的病患数量，根据药品信息和病患数量确定待监控医疗单位的人日均药品费用（S13）；根据药品信息中所包括的各类药品的药品信息确定出用药处方中的目标药品并确定目标药品在用药处方中的目标药品比例；确定日均药品费用、人日均药品费用以及目标药品比例是否大于待监控医疗单位的用药指标参数阈值（S15）；若是，则向待监控医疗单位发送药品费用超标预警信息，基于药品费用超标预警信息进行药品费用控制。采用该方法，可提高用药监控的准确性，提高医疗资源的有效利用率。

Description

基于数据处理的药品费用控制方法及装置
本申请要求于2018年10月22日提交中国专利局、申请号为201811232900.3、申请名称为“基于数据处理的药品费用控制方法及装置”的中国专利申请的优先权，其全部内容通过引用结合在本申请中。
技术领域
本申请涉及医疗技术领域，尤其涉及一种基于数据处理的药品费用控制方法及装置。
背景技术
当前为了规范各个医疗单位的用药标准，规避大处方行为，从而避免药品的滥用和浪费，起到合理施治的目的，各式各样的用药监控机制应运而生。各式各样的用药监控机制用于对各个医疗单位进行用药监控，包括但不限于各个医院、各个医院的科室、各个诊所乃至各个医师等医疗单位(或者医疗单位的代表)进行用药监控。
现有技术中，对于各个医疗单位的用药标准的评价主要是采用次均处方标准，也就是将每次计算的处方平均费用(简称次均处方费用)作为各个医疗单位的用药评价标准。其中，上述次均处方费用的用药评价标准是采用处方总额除以处方数量的方式来计算得到。现有技术采用次均处方费用作为各个医疗单位的用药评价标准导致各个医疗单位为了规避大处方行为被考核，通常会采用缩减处方天数来减低次均处方费用，或者通过分解处方的方式将单个处方总额较大的大处方分解为多个单个处方总额较小的小处方等方式来降低次均处方费用，从而规避大处方的监控。现有技术的实现方式使得各个医疗单位的用药监控的漏洞较大，对各个医疗单位的用药监控准确率低，适用性差。
发明内容
本申请实施例提供一种基于数据处理的药品费用控制方法及装置，操作简单，可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，提高医疗资源的有效利用率，适用性更强。
第一方面，本申请实施例提供了一种基于数据处理的药品费用控制方法，该方法包括：
获取待监控医疗单位的用药处方；
获取上述用药处方中所包括的药品信息，并根据上述药品信息确定上述待监控医疗单位的日均药品费用；
根据上述用药处方中包括的病患信息确定上述用药处方所对应的病患数量，根据上述药品信息和上述病患数量确定上述待监控医疗单位的人日均药品费用；
根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例；
确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例是否大于上述待监控医疗单位的用药指标参数阈值；
若上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值，则向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
第二方面，本申请实施例提供了一种基于数据处理的药品费用控制装置，该用药监控装置包括：
数据获取单元，用于获取待监控医疗单位的用药处方，并获取上述用药处方中所包括的药品信息；
药品信息处理单元，用于根据上述数据获取单元获取的上述药品信息确定上述待监控医疗单位的日均药品费用；
药品信息处理单元，还用于根据上述数据获取单元获取的上述用药处方中包括的病患信息确定上述用药处方所对应的病患数量，根据上述药品信息和上述病患数量确定上述待监控医疗单位的人日均药品费用；
药品信息处理单元，还用于根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例；
药品费用监控单元，用于确定上述药品信息处理单元确定的上述日均药品费用、上述人日均药品费用以及上述目标药品比例是否大于上述待监控医疗单位的用药指标参数阈值；
药品费用控制单元，用于在上述药品费用监控单元确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值时，向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
第三方面，本申请实施例提供了一种终端设备，该终端设备包括处理器、收发器和存储器，该处理器、收发器和存储器相互连接。该存储器用于存储支持该终端设备执行上述第一方面和/或第一方面任一种可能的实现方式提供的方法的计算机程序，该计算机程序包括程序指令，该处理器和收发器被配置用于调用上述程序指令，执行上述第一方面和/或第一方面任一种可能的实施方式所提供的方法。
第四方面，本申请实施例提供了一种计算机可读存储介质，该计算机可读存储介质存储有计算机程序，该计算机程序包括程序指令，该程序指令当被处理器执行时使该处理器执行上述第一方面和/或第一方面任一种可能的实施方式所提供的方法。
基于本申请实施例提供的方法可基于多个用药指标参数(即日均药品费用、人日均药品费用和目标药品比例)实现对各医疗单位的用药监控操作简单，可提高对医疗单位的药品费用控制的时效性，提高对医疗单位的用药监控的可靠性，提高医疗资源的有效利用率，适用性更强。
附图说明
图1是本申请实施例提供的基于数据处理的药品费用控制方法的一流程示意图；
图2是本申请实施例提供的基于数据处理的药品费用控制方法的另一流程示意图；
图3是本申请实施例提供的基于数据处理的药品费用控制装置的实施例结构示意图；
图4是本申请实施例提供的终端设备的实施例结构示意图。
具体实施方式
本申请实施例提供了一种基于数据处理的药品费用控制方法，可基于各个医院、各个医院的科室、各个诊所乃至各个医师等医疗单位(或者医疗单位的代表(或称团队))的日均药品费用、人日均药品费用和目标药品比例来评价各个医疗单位(包括医院、科室、诊所或者医师)的药品费用是否超标(或称是否合理)。若待监控医疗单位的多个用药指标参数中有一项或者多项用药指标参数超标时，则可基于待监控医疗单位的日均药品费用、人日均药品费用和目标药品比例中的一项或者多项向待监控医疗单位发送药品费用超标预警信息，以向待监控医疗单位发出控制开方用药的药品费用、防止待监控医疗单位的药品费用持续超标的预警，避免待监控医疗单位的药品等医疗资源的浪费。可选的，可基于医疗单位的用药情况在医疗单位的药品费用超标时拒绝该医疗单位提交的药品费用报销请求和/或理赔请求，以实现对该医疗单位的药品费用超标的预警，提醒医疗单位对处方药品费用进行控制，避免医疗资源的浪费。这里，人日均药品费用是指平均一个人的日均药品费用，下面将结合日均药品费用进行说明。为方便描述，上述各个医院、各个医院的科室、各个诊所乃至各个医师等等医疗单位或者医疗单位的代表所表示的考核维度将以医疗单位的这个考核维度为例进行说明，下面不再赘述。
目前，各个地区的贵重药品的确定是将最小包装单位(例如一瓶、一包、一盒或者一袋等)的单价药品超过某一个阈值的药品确定为贵重药品。然而，这种方法确定贵重药品没有考虑最小包装单位的单价药品的使用天数问题，因此可能存在的弊端是单价相同的药品或者某个低价药品或者某个高价药品由于使用天数不同，导致药品的单价较高但是单日均价较低的倒挂情况。比如某药品单盒售价为300元，按照目前各地区的贵重药品判定方式判定为贵重药品；该贵重药品一盒可使用30天，也就是该药品的单日均价是10元/天。另外一个药品单盒售价为120元，按照目前各地区的贵重药品判定方式判定为非贵重药品；该药品一盒可以用3天，也就是该药品的单日均价是40元/天。由此可见，按照目前各地区的贵重药品的判定方式判定的非贵重药品的单日均价超出了贵重药品的单日均价，显而易见，该判定方式对贵重药品的评估准确率低，使得贵重药品的考核漏洞较大。在一些可行的实施方式中，本申请实施例提供的目标药品可为贵重药品，这里贵重药品的确定方式与上述目前各地区的贵重药品的确定方式不同。这里，贵重药品可为用药处方中所包括的各类药品中的单药日均药品费用较高且在该用药处方所包括的各类药品的单药日均药品费用中排序靠前的药品。下面将以贵重药品为例，结合本申请实施例提供的基于数据处理的药品费用超标预警方法进行描述。对应的，目标药品比例可以贵重药品比例为例进行说明，下面不再赘述。
本申请实施例所提供的用药处方可包括各个医疗单位的各个医师针对各个病患的病症所开具的处方，或称各个医师针对各个病患的病症所开具的药方，或称处方笺等，在此不做限制。为方便描述，下面将以处方为例进行说明。通常来讲，各个医疗单位的各个医师所开具的处方中可包括但不限于处方开具时间、处方编号、科室编号、病患信息(包括病患个人信息)、药品详情以及医师签字，具体可根据实际应用场景确定，在此不做限制。换句话说，无论是单个处方总额较大的大处方，还是单个处方总额较小的小处方，或者其他更多表现形式的处方，每个处方中均会有医疗单位开具的药品详情，包括但不限于药品名称、药品金额、药品使用方式以及药品使用天数等。基于各个处方中所包括的药品详情可确 定出单药日均药品费用较高且排序靠前的药品作为贵重药品，进而可基于贵重药品的费用在所有处方中的药品总费用的比例(即贵重药品比例)来确定用药是否合理。因此无论是大处方还是小处方还是其他，均离不开药品详情。
在一些可行的实施方式中，基于医疗单位的日均药品费用、人日均药品费用和贵重药品比例对医疗单位进行用药监控时可每天对医疗单位的用药情况进行监控，进而可每天结算医疗单位的用药处方的日均药品费用、人日均药品费用和贵重药品比例，基于每天的日均药品费用、人日均药品费用和贵重药品比例对医疗单位的用药情况进行监控。可选的，基于每天的日均药品费用、人日均药品费用和贵重药品比例对医疗单位进行用药监控的同时，也可基于累计多天的用药监控情况对医疗单位进行用药情况的综合评价等，例如一个星期、一个月、一个季度或者一年等。为方便描述，下面将以任一日(为方便描述下面将以单日为例进行说明)的日均药品费用、人日均药品费用和贵重药品比例的计算以及基于每日的日均药品费用、人日均药品费用和贵重药品比例对医疗单位的用药情况进行监控和/或评价为例，对本申请实施例提供的基于数据处理的药品费用控制方法进行描述。
本申请实施例提供的基于数据处理的药品费用控制方法可由药品监督管理局、卫生委员会、卫生与健康委员会以及医疗理赔单位等用药监控单位所关联的终端设备执行，例如上述用药监控单位用于对各个医疗单位进行用药监控的客户端和/或人机交互设备等，在此不做限制。例如，当上述用药监控单位为待监控医疗单位自身时，上述终端设备可以是待监控医疗单位用于对各个医师的开方用药情况进行药品费用控制和药品费用超标预警的工具，例如医师开方工具等等，在此不做限制。当上述用药监控单位为待监控医疗单位之外的其他单位时，上述终端设备可以是用于对各个医疗单位进行用药监控的客户端和/或人机交互设备等，在此不做限制。为方便描述，下面将以终端设备为例进行说明。
实施例一：
参见图1，图1是本申请实施例提供的基于数据处理的药品费用控制方法的一流程示意图。本申请实施例提供的基于数据处理的药品费用控制方法，可通过如下步骤S11至S16中各个步骤所提供的实现方式进行说明。
S11，获取待监控医疗单位的用药处方。
在一些可行的实施方式中，上述待监控医疗单位可为用药监控单位所监控的任一医疗单位，具体可根据实际应用场景确定，在此不做限制。换句话说，任一医疗单位都可能被用药监控单位作为监控对象，因此被选中的监控对象则可为待监控医疗单位。为方便描述，下面将以待监控医疗单位为例进行说明。
在一些可行的实施方式中，上述医疗单位的用药处方可包括待监控医疗单位在单日内所产生的所有用药处方。为方便描述，上述待监控医疗单位在单日内所产生的所有用药处方可以单日处方为例进行说明。上述医疗单位的单日处方可以是指医疗单位的任一日所开具的所有处方，包括但不限于单日内医院的所有科室所有医师所开具的所有处方、单日内医院的某一个科室的所有医师所开具的所有处方，或者单日内医院的某一个科室的某一个医师所开具的所有处方中的任一种情况。其中，上述单日处方所表示的具体情况根据实际应用场景中对医疗单位进行用药监控的考核维度(例如针对医疗单位进行用药监控、针对医疗单位的某一个科室进行用药监控或者针对医疗单位的某一个科室的某一个医师进行用药监控等)确定，在此不做限制。为方便描述，下面将以单日内医院的所有科室所有医师所开具的所有处方为例进行说明，以下简称单日处方。举例来说，假设医疗单位的所有医师一天所开具的所有处方合计为S(例如80)张处方，其中，这80张处方中一张处方针对一病患人次，因此这80张处方对应的病患数量为80。换句话说，80张处方中可能有多张处方对应同一个病患，然而这多张处方对应的病患依然以病患人次计算，因此处方总数(80)则为所有处方所对应的病患数量，下面不再赘述。假设，上述80张处方中各张处方所包括的药品数量累计相加为K(例如药品总数为200)个，则基于这200个药品中各药品详情可计算得到日均药品费用。进一步的，基于80张处方(对应病患数量为80)所包括的200个药品，结合上述日均药品费用则可计算得到该医疗单位的人日均药品费用。基于上述80张处方中所包括的200个药品中各类药品的药品详情，可从上述200个药品中确定出贵重药品以及贵重药品比例，从而可基于日均药品费用、人日均药品费用和贵重药品比例对医疗单位的用药情况进行监控。
在一些可行的实施方式中，上述待监控医疗单位的单日处方可以是用于对待监控医疗单位进行实时药品费用超标预警的处方，这部分处方可以是待监控医疗单位单日内各个医师所开具的处方中的全部或者部分。这里，对待监控医疗单位的实时药品费用超标预警可以是在待监控医疗单位的日均药品费用、人日均药品费用和贵重药品比例等用药指标参数来到用药指标参数超标的临界点(即日均药品费用等于日均药品费用阈值、人日均药品费用等于人日均药品费用阈值和/或贵重药品比例等于贵重药品比例阈值) 时生成，用于实时告知待监控医疗单位的医师接下来开具的处方可能会导致待监控医疗单位的日均药品费用、人日均药品费用和/或贵重药品比例等用药指标参数超标的处方，以供医师确定是否继续开具处方。可选的，上述待监控医疗单位的单日处方也可以是用于对待监控医疗单位进行后期药品费用超标预警的处方，这部分处方可以是待监控医疗单位单日内各个医师所开具的所有处方。这里，后期药品费用超标预警可以是在基于待监控医疗单位当前考核周期(例如某一天)的单日处方确定待监控医疗单位的日均药品费用、人日均药品费用和贵重药品比例等用药指标参数超标(即日均药品费用大于日均药品费用阈值、人日均药品费用大于人日均药品费用阈值和/或贵重药品比例大于贵重药品比例阈值)时生成，并在确定待监控医疗单位在当前考核周期的日均药品费用、人日均药品费用和/或贵重药品比例等用药指标参数超标时向待监控医疗单位发出药品费用超标预警，以提示待监控医疗单位注意后续考核周期内的日均药品费用、人日均药品费用和/或贵重药品比例等用药指标参数的控制以防止再次出现日均药品费用、人日均药品费用和/或贵重药品比例等用药指标参数超标而遭受药品费用拒绝报销和/或拒绝理赔等惩罚。其中，上述待监控医疗单位的单日处方的具体表现形式可根据实际应用场景中药品费用超标预警的应用场景(实时或者后期)需求确定，在此不做限制。为方便描述，下面单日处方将以实时获取到的处方为例进行说明，包括但不限于医疗单位的各个科室的各个医师所开具的处方中的全部或者部分。
在一些可行的实施方式中，终端设备可与待监控医疗单位的数据系统对接，获取待监控医疗单位的数据系统准入资格，进而可基于待监控医疗单位的数据系统准入资格从待监控医疗单位的数据系统中获取待监控医疗单位的处方，例如待监控医疗单位的单日处方等。可选的，终端设备也可基于待监控医疗单位所提供了医疗理赔数据，从医疗理赔数据中筛选得到医疗单位的单日处方等处方数据。可选的，终端设备也可基于大数据分析，从各个医疗单位的病患就诊记录中筛选得到待监控医疗单位的单日处方等处方数据，等等。终端设备可基于上述数据获取方式之外的任一数据获取路径获取得到待监控医疗单位的单日处方，具体可根据实际应用场景确定，在此不做限制。
可以理解，这里待监控医疗单位的单日处方中任一处方上均可包括该处方中所开药品的药品详情，包括但不限于药品名称、药品金额，药品使用方式(或称药品服用方式等)以及药品使用天数，具体可根据实际应用场景确定，在此不做限制。
S12，获取上述用药处方中所包括的药品信息，并根据上述药品信息确定上述待监控医疗单位的日均药品费用。
在一些可行的实施方式中，基于待监控医疗单位的单日处方可以确定待监控医疗单位的单日处方中所有处方所包括各药品的药品信息，其中，任一药品的药品信息中包括但不限于药品金额和药品使用天数。基于上述待监控医疗单位的单日处方中所有处方所包括的各药品的药品信息可确定待监控医疗单位的单日处方中所包括的药品总数、药品总额以及药品使用总天数等等。其中，上述任一药品的药品金额为任一药品的单价和数量相乘得到单个药品的价格。上述药品总数表示单日处方中所有处方中所使用的药品累加之后的药品总数。上述药品总额为基于单日处方中所包括的每个药品的单价和数量相乘得到单个药品的药品金额之后，再将单日处方中所包括的所有药品的药品金额进行累加得到所有药品的药品总价(即药品总额)。上述药品使用总天数为单日处方中所有药品中每个药品的药品使用天数的累加值。待监控医疗单位的单日处方的日均药品费用表示待监控医疗单位单日处方中所包括的所有药品的平均费用，这里可以日均药品费用进行说明。其中，上述待监控医疗单位的单日处方的日均药品费用可基于如下公式(1)计算得到：
公式(1)：日均药品费用＝药品总额/药品使用总天数。
其中，在上述公式(1)中药品总额即单日处方中所有药品的药品金额累加得到的所有药品的总价，上述药品使用总天数即单日处方中所有药品中每个药品的药品使用天数的累加值。
S13，根据上述用药处方中包括的病患信息确定上述用药处方所对应的病患数量，根据上述药品信息和上述病患数量确定上述待监控医疗单位的人日均药品费用。
在一些可行的实施方式中，上述用药处方中包括的病患信息可包括病患姓名、病患身份证号、病患年龄以及病患性别等病患个人信息，具体可根据实际应用场景确定，在此不做限制。其中，上述用药处方中一个用药处方针对一病患人次，因此根据上述用药处方中所包括的病患信息可确定用药处方所对应的病患数量。这里，病患数量等于用药处方的处方总数，具体可参见上述步骤S11所描述的实现方式，在此不再赘述。
在一些可行的实施方式中，基于上述单日处方中各处方所包括的药品详情计算得到日均药品费用之后，还可基于上述病患数量(即用药处方的处方总数，例如S＝80)和上述80张处方所包括的药品总数 (例如K＝200)，结合上述日均药品费用则可计算得到该医疗单位的人日均药品费用。其中，上述人日均药品费用的计算可满足如下公式(2)：
公式(2)：人日均药品费用＝药品总数/病患数量*日均药品费用。
其中，如上述公式(2)可知，当上述单日处方所包括的药品总数为K个(例如200个)，上述单日处方所对应的病患数量为S(例如S＝80，即单日处方的处方总数是80张)时，上述人日均药品费用可满足如下公式(3)：
公式(3)：人日均药品费用＝S/K*日均药品费用＝200/80*日均药品费用。
在一些可行的实施方式中，简单使用日均药品费用对医疗单位进行用药监控可能会导致医疗单位利用增加处方药品种类等方式来使得单药的日均药品费用达标，规避基于日均药品费用的用药监控，但是人日均药品费用还是超标了。因此，基于日均药品费用，计算人日均药品费用可在日均药品费用的基础上，增加基于人均维度上的药品费用监控，从而可更好地对医疗单位的用药进行监控，操作更灵活，适用性更强。
S14，根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例。
在一些可行的实施方式中，基于上述医疗单位的日均药品费用的计算方式相同的原理，终端设备还可计算得到医疗单位的单日处方中每类药品的日均药品费用。其中，任一类药品的日均药品费用下面可以单药日均药品费用为例进行说明。基于上述待监控医疗单位的单日处方，可获取所有用药处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数。根据上述单日处方中各类药品的药品信息确定出上述单日处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数，根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用。其中，上述任一类药品的单药日均药品费用的计算可满足如下公式(4)：
公式(4)：单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
其中，在上述公式(4)中任一类药品总额即单日处方的所有药品中某一个种类(为方便描述以任一类进行描述)的药品的价格累加得到的单药药品总价，上述任一类药品使用总天数即单日处方的所有药品中该种类药品药品的使用天数的累加值。
基于上述公式(4)所提供的实现方式，结合待监控单位的单日处方中所包括的各类药品的药品信息可确定待监控医疗单位的单日处方中各类药品的单药日均药品费用，进而可基于上述各类药品的单药日均药品费用确定出单日处方中的贵重药品。
在一些可行的实施方式中，根据上述实现方式确定的各类药品的单药日均药品费用，可确定出待监控单位的单日处方对应的单药日均药品费用阈值，并将上述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的药品确定为待监控医疗单位的单日处方中的贵重药品。这里，贵重药品是指单药日均药品费用在单日处方的所有药品的单药日均药品费用中费用较高且单药日均药品费用大于或者等于单药日均药品费用阈值的药品。换句话说，基于单日处方中各类药品的单药日均药品费用可将各类药品的单药日均药品费用按照从高到低的顺序进行排序，进而可从单药日均药品费用排序靠前的一部分(例如20％)药品中单药日均药品费用最低的一个确定为单药日均药品费用阈值，此时这部分(即20％)的药品中各药品的单药日均药品费用均大于或者等于单药日均药品费用阈值，进而可将这部分(即20％)的药品确定为贵重药品。比如，在单日处方的所有药品中，根据各类药品的单药日均药品费用确定单药日均药品费用为x元/天(即单药日均药品费用阈值)，例如11元/天的药品则为贵重药品。换句话说，就是待监控医疗单位的单日处方中所包括的所有药品中有20％的药品是单药日均药品费用大于或者等于11元/天的药品，这部分药品则为贵重药品。
在一些可行的实施方式中，根据上述各类药品的药品信息可确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述贵重药品的贵重药品总额。根据上述所有药品的药品总额和上述贵重药品总额可确定出待监控医疗单位的单日处方中的贵重药品比例。这里，贵重药品比例可以是单日处方中贵重药品的药品总额在单日处方的所有药品的药品总价格中的比例，也就是说贵重药品比例满足如下公式(5)：
公式(5)：贵重药品比例＝贵重药品总额/所有药品的药品总额。
在上述公式(5)中，贵重药品总额为单日处方中各类贵重药品的价格累计值，其中，每类贵重药品的价格为该类贵重药品的数量与该类贵重药品的单价的乘积。上述所有药品的药品总额为单日处方中 各类药品的价格累加值。
S15，确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例是否大于上述待监控医疗单位的用药指标参数阈值。
在一些可行的实施方式中，针对不同医疗单位进行用药监控时，可预先设定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，例如日均药品费用阈值，即日均药品费用的达标上限(或称日均药品费用上限)等。例如，针对待监控医疗单位进行用药监控时，可基于待监控医疗单位的历史用药记录或者药品使用政策等信息设定待监控医疗单位对应的日均药品费用阈值，进而可基于上述确定的待监控医疗单位的日均药品费用，结合待监控医疗单位对应的日均药品费用阈值可确定该医疗单位的日均药品费用是否达标。换句话说，就是待监控医疗单位的日均药品费用是否小于或者等于其对应的日均药品费用阈值。若待监控医疗单位的日均药品费用小于或者等于其对应的日均药品费用阈值，则可确定待监控医疗单位的日均药品费用是达标的。若待监控医疗单位的日均药品费用大于其对应的日均药品费用阈值，则可确定待监控医疗单位的日均药品费用是超标的，此时，上述日均药品费用可为待监控医疗单位的超标用药指标参数之一。
在一些可行的实施方式中，针对不同医疗单位进行用药监控时，还可预先设定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，例如人日均药品费用阈值，即人日均药品费用的达标上限(或称人日均药品费用上限)等。例如，针对待监控医疗单位进行用药监控时，可基于待监控医疗单位的历史用药记录或者药品使用政策等信息设定待监控医疗单位对应的人日均药品费用阈值，进而可基于上述确定的待监控医疗单位的人日均药品费用，结合待监控医疗单位对应的人日均药品费用阈值确定该医疗单位的人日均药品费用是否达标。换句话说，就是待监控医疗单位的人日均药品费用是否小于或者等于其对应的人日均药品费用阈值。若待监控医疗单位的人日均药品费用小于或者等于其对应的人日均药品费用阈值，则可确定待监控医疗单位的人日均药品费用是达标的。若待监控医疗单位的人日均药品费用大于其对应的人日均药品费用阈值，则可确定待监控医疗单位的人日均药品费用是超标的，此时，上述人日均药品费用可为待监控医疗单位的超标用药指标参数之一。
在一些可行的实施方式中，针对不同医疗单位进行用药监控时，可预先设定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，例如贵重药品比例阈值，即贵重药品比例的达标上限(或称贵重药品比例上限)等。例如，针对待监控医疗单位进行用药监控时，可基于待监控医疗单位的历史用药记录或者药品使用政策等信息设定待监控医疗单位对应的贵重药品比例阈值，进而可基于上述确定的待监控医疗单位的贵重药品比例，结合待监控医疗单位对应的贵重药品比例阈值确定该医疗单位的贵重药品比例是否达标。换句话说，就是待监控医疗单位的贵重药品比例是否小于或者等于其对应的贵重药品比例阈值。若待监控医疗单位的贵重药品比例小于或者等于其对应的贵重药品比例阈值，则可确定待监控医疗单位的贵重药品比例是达标的。若待监控医疗单位的贵重药品比例大于其对应的贵重药品比例阈值，则可确定待监控医疗单位的贵重药品比例是超标的，此时，上述贵重药品比例可为待监控医疗单位的超标用药指标参数之一。
可选的，在一些可行的实施方式中，对待监控医疗单位进行用药监控时，可基于待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数进行综合评价。若上述待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数均达标，则可确定待监控医疗单位的药品费用不超标。若上述待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数中有一个以及一个以上超标，则可确定待监控医疗单位的药品费用超标。比如，若上述日均药品费用小于或者等于上述日均药品费用阈值、上述人日均药品费用小于或者等于上述人日均药品费用阈值，且上述贵重药品比例小于或者等于上述贵重药品比例阈值，则确定上述待监控医疗单位的药品费用不超标。或者，若上述日均药品费用小于或者等于上述日均药品费用阈值、上述人日均药品费用小于或者等于上述人日均药品费用阈值以及上述贵重药品比例小于或者等于上述贵重药品比例阈值中有一项或者多项成立，则确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值。换句话说，此时可确定上述待监控医疗单位的药品费用超标或者临近超标。
S16，若上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值，则向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
在一些可行的实施方式中，在针对待监控医疗单位进行实时药品费用超标预警的药品费用控制场景 中，若基于待监控医疗单位在当前考核周期已经开具的处方确定待监控医疗单位的药品费用超标。即在待监控医疗单位的日均药品费用、人日均药品费用以及目标药品比例等用药指标参数大于其对应的用药指标参数阈值时，当终端设备获取到待监控医疗单位的任一医师提交的开方请求时，可输出药品费用超标预警标识至待监控医疗单位的医师开方工具首页，基于医师开方工具首页上显示的药品费用超标预警标识，向待监控医疗单位的医师发出药品费用超标预警，以提示待监控医疗单位的医师进行开方用药的药品费用控制以防止药品费用超标。例如，当终端设备获取到待监控医疗单位的任一医师提交的开方请求时，可在该医师的开方工具首页(例如开方工具的用户操作界面)上输出药品费用超标预警的标志(例如红色感叹号等)或者药品费用超标预警的语音信息等药品费用超标预警信息。基于上述药品费用超标预警信息提示待监控医疗单位的医师，待监控医疗单位当前考核周期的处方对应的日均药品费用已经到达达标上限(即待监控医疗单位在当前考核周期内的处方对应的日均药品费用已经大于或者等于日均药品费用阈值)，医师接下来开具的处方所带来的药品费用可能会导致待监控医疗单位在当前考核周期内药品费用超标，以供医师确定是否继续开方等。基于上述实现方式可提示待监控医疗单位的医师控制开方用药以防止药品费用超标，从而可实现对待监控医疗单位的药品费用超标的预警。
可选的，在一些可行的实施方式中，在针对待监控医疗单位的后期药品费用超标预警的药品费用控制场景中，当上述待监控医疗单位的药品费用超标，根据上述日均药品费用、上述人日均药品费用、上述目标药品比例以及上述用药指标参数阈值(包括日均药品费用阈值、人日均药品费用阈值以及目标药品比例阈值)确定上述待监控医疗单位在上述当前考核周期内的药品费用超标数据。根据上述药品费用超标数据向待监控医疗单位发送药品费用超标预警信息，基于药品费用超标预警信息提示待监控医疗单位在当前考核周期之后的一个或者多个考核周期内进行开方用药的药品费用控制。
例如医疗单位的日均药品费用大于日均药品费用阈值时，可确定上述待监控医疗单位的日均药品费用中超出日均药品费用阈值部分的日均药品费用差值(即药品费用超标数据)。根据上述药品费用超标数据向待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位在当前考核周期之后的一个或者多个考核周期内进行开方用药的药品费用控制。其中，上述药品费用超标预警信息包括即时通讯信息、邮件或者告示中的一种或者多种信息类型。例如，终端设备可将上述日均药品费用以及上述日均药品费用差值进行公示，基于公示的日均药品费用以及上述日均药品费用差值提示待监控医疗单位的医师控制开方用药的药品费用，避免该待监控医疗单位的医师在开方过程中随意用药造成药品等医疗资源的浪费，实现对待监控医疗单位的药品费用控制。可选的，基于上述日均药品费用以及上述日均药品费用差值可在该待监控医疗单位的单位大厅公告界面(例如单位大厅的消息公告显示屏)上进行公示或者在用药监管单位所出的医疗单位用药监控日报上进行公示，以控制待监控医疗单位及其各个医师开方的用药，避免待监控医疗单位的用药处方的日均药品费用持续超标带来的医疗资源浪费，实现对该待监控医疗单位的药品费用控制。可选的，基于上述日均药品费用以及上述日均药品费用差值也可在该待监控医疗单位的各个科室的信息公告界面上进行公示，和/或在该待监控医疗单位的各个医师的开方工具的首页上进行公示等，具体可根据实际应用场景确定，在此不做限制。
基于本申请实施例提供的方法可基于多个用药指标参数实现对待监控医疗单位的用药综合评价，实现对各医疗单位的用药监控操作简单，用药监控的考核维度更全面，进而可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，可提高基于各个医疗单位的用药情况对各个医疗单位的处方进行超标用药指标参数的公示等用药处方的药品费用超标预警的准确性，提高该医疗单位开方的用药可控性，从而可提高医疗资源的有效利用率，适用性更强。
实施例二：
参见图2，图2是本申请实施例提供的基于数据处理的药品费用控制方法的另一流程示意图。本申请实施例提供的基于数据处理的药品费用控制方法可实现对待监控医疗单位在多日的单个考核周期内的用药情况进行监控，该方法可通过如下步骤S21至S27中各个步骤所提供的实现方式进行说明。
S21，获取待监控医疗单位的用药处方。
在一些可行的实施方式中，上述获取待监控医疗单位的用药处方的实现方式可参见上述实施例中步骤S11所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，上述医疗单位的用药处方还可包括待监控医疗单位在多日的单个考核周期内产生的所有用药处方。换句话说，上述单个考核周期大于一日，例如一个星期、一个月、一个季度或者一年等，在此不做限制。为方便描述，上述待监控医疗单位在多日的单个考核周期内所产生的所有用药处方可以单考核周期处方为例进行说明。
可选的，上述医疗单位的单考核周期处方可以是指医疗单位的任一考核周期内所开具的所有处方，包括但不限于单个考核周期内医院的所有科室所有医师所开具的所有处方、单个考核周期内医院的某一个科室的所有医师所开具的所有处方，或者单个考核周期内医院的某一个科室的某一个医师所开具的所有处方中的任一种情况。其中，上述单考核周期处方所表示的具体情况根据实际应用场景中对医疗单位进行用药监控的考核维度(例如针对医疗单位进行用药监控、针对医疗单位的某一个科室进行用药监控或者针对医疗单位的某一个科室的某一个医师进行用药监控等)确定，在此不做限制。为方便描述，下面将以单个考核周期内医院的所有科室所有医师所开具的所有处方为例进行说明，以下简称单考核周期处方。
可以理解，这里待监控医疗单位的单考核周期处方中所包括的任一处方上均可包括该处方中所开药品的药品详情，包括但不限于药品名称、药品金额，药品使用方式以及药品使用天数，具体可根据实际应用场景确定，在此不做限制。
S22，获取上述用药处方中所包括的药品信息，并根据上述药品信息确定所述待监控医疗单位的日均药品费用。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的药品信息确定待监控医疗单位的日均药品费用的具体实现方式可参见上述实施例中步骤S12所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，基于上述待监控医疗单位的用药处方的日均药品费用还可处理得到指定时间段内待监控医疗单位的日均药品费用，例如，一个星期，一个月，一个季度或者一年的日均药品费用等。为方便描述，下面可以一个星期作为一个考核周期，以一个星期的日均药品费用为例进行说明，简称单考核周期处方的日均药品费用。
可选的，单考核周期处方的日均药品费用可满足如下公式(6):
公式(6)：日均药品费用＝周期药品总额/周期药品使用总天数。
其中，在上述公式(6)中周期药品总额可以是单个考核周期内的所有处方中所包括的所有药品的药品金额累加得到的所有药品的总金额，上述周期药品使用总天数可以是单考核周期处方所包括的所有药品中每个药品的药品使用天数的累加值。
可选的，在一些可行的实施方式中，基于待监控医疗单位的单考核周期处方中所包括的药品信息，可获取单个考核周期内任一日的任一单日用药处方，并获取任一单日用药处方中所包括的各药品的药品信息，其中药品信息中包括但不限于药品金额和药品使用天数。根据任一单日用药处方所包括的各药品的药品金额和药品使用天数确定待监控医疗单位任一日的单日日均药品费用。其中，上述待监控医疗单位的任一日的单日日均药品费用可参见上述实施例中公式(1)对应的实现方式，在此不再赘述。此外，基于待监控医疗单位在单个考核周期内每日处方中所包括的各药品的药品使用天数可确定每日处方中的药品使用总天数，进而可基于每日处方的药品使用总天数确定待监控医疗单位的单考核周期处方中所包括的所有药品的药品使用总天数。其中，待监控医疗单位在单个考核周期内的任一日的药品使用总天数为任一单日处方中所包括的各药品的药品使用天数的总和。根据上述待监控医疗单位在单个考核周期内各日的单日日均药品费用和药品使用总天数可确定待监控医疗单位在单个考核周期内的日均药品费用。
在一些可行的实施方式中，根据上述单个考核周期内各日的单日日均药品费用可确定待监控医疗单位在单个考核周期的单日日均药品费用的累加值，为方便描述可简称单日日均药品费用累加值。根据上述单个考核周期内各日的药品使用总天数可确定待监控医疗单位在单个考核周期内的药品使用总天数的累加值，为方便描述可简称药品使用总天数累加值。根据上述单日日均药品费用累加值和上述药品使用总天数累加值确定待监控医疗单位的日均药品费用。
这里，待监控医疗单位的日均药品费用(即待监控医疗单位在单个考核周期内的日均药品费用)可满足如下公式(7):
公式(7)：日均药品费用＝单日日均药品费用累加值/药品使用总天数累加值。
假设，这里单个考核周期为一个星期，则在上述公式(7)中的单日日均药品费用累加值可以是一个星期内的7个单日处方中各个单日处方的日均药品费用的累加值，上述公式(7)中的药品使用总天数累加值可以是一个星期内的7个单日处方中各个单日处方的药品使用总天数的累加值。
S23，根据上述日均药品费用、上述病患数量和上述药品总数确定上述待监控医疗单位的人日均药品费用。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的病患信息确定用药处方所 对应的病患数量的实现方式，以及基于上述用药处方所包括的药品信息确定待监控医疗单位的人日均药品费用的具体实现方式可参见上述实施例中步骤S13所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，上述所有用药处方中的药品总数为上述多日的单个考核周期中各日的用药处方中所包括药品的累加值，为方便描述可简称为药品总数。上述病患数量等于上述多日的单个考核周期中所有用药处方的处方总数。基于上述确定的日均药品费用、上述病患数量(即用药处方的处方总数，例如S＝80)和上述80张处方所包括的药品总数(例如K＝200)则可计算得到该医疗单位的人日均药品费用。其中，上述人日均药品费用的计算可满足如下公式(8)：
公式(8)：人日均药品费用＝药品总数/病患数量*日均药品费用。
其中，如上述公式(8)可知，假设上述多日的所有用药处方所包括的药品总数为K个(例如200个)，上述多日的所有用药处方所对应的病患数量为S(例如S＝80，即处方总数是80张)时，上述人日均药品费用可满足如下公式(9)：
公式(9)：人日均药品费用＝S/K*日均药品费用＝200/80*日均药品费用。
其中，上述人日均药品费用的计算可参见上述实施例中步骤S13所提供的实现方式，在此不再赘述。
S24，根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的药品信息确定待监控医疗单位的各类药品的单药日均药品费用的具体实现方式可参见上述实施例中步骤S14所提供的实现方式，在此不再赘述。
进一步的，在一些可行的实施方式中，基于上述医疗单位的日均药品费用的计算方式相同的原理，终端设备还可计算得到医疗单位的多日的单个考核周期内的所有处方中每类药品的单药日均药品费用。基于上述待监控医疗单位的单个考核周期内的所有处方，可获取所有处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数。根据上述单个考核周期内的所有处方中各类药品的药品信息确定出上述单个考核周期内的所有处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数，根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用。其中，上述任一类药品的单药日均药品费用的计算可满足如下公式(10)：
公式(10)：单药日均药品费用＝单个考核周期内任一类药品的药品总额/单个考核周期内任一类药品的药品使用总天数。
其中，在上述公式(10)中任一类药品总额即单个考核周期内的所有处方的所有药品中某一个种类(为方便描述以任一类进行描述)的药品的价格累加得到的单药药品总价，上述单个考核周期内任一类药品使用总天数即单个考核周期内的所有处方的所有药品中该种类药品药品的使用天数的累加值。
基于上述公式(10)所提供的实现方式，结合待监控单位的单个考核周期内的所有处方中所包括的各类药品的药品信息可确定待监控医疗单位的单个考核周期内的所有处方中各类药品的单药日均药品费用，进而可基于上述各类药品的单药日均药品费用确定出单个考核周期内的所有处方中的贵重药品。
这里，贵重药品比例可以是单个考核周期内的所有处方中贵重药品的药品总额在单个考核周期内的所有处方的所有药品的药品总价格中的比例，也就是说贵重药品比例满足如下公式(11)：
公式(11)：贵重药品比例＝贵重药品总额/所有药品的药品总额。
在上述公式(11)中，贵重药品总额为单个考核周期内的所有处方中各类贵重药品的价格累计值，其中，每类贵重药品的价格为该类贵重药品的数量与该类贵重药品的单价的乘积。上述所有药品的药品总额为单个考核周期内的所有处方中各类药品的价格累加值。
S25，根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的日均药品费用阈值、人日均药品费用阈值以及目标药品比例阈值。
S26，根据上述日均药品费用、上述人日均药品费用以及上述目标药品比例，结合上述日均药品费用阈值、人日均药品费用阈值以及所述目标药品比例阈值，确定上述待监控医疗单位的药品费用是否超标。
在一些可行的实施方式中，上述根据待监控医疗单位的日均药品费用、上述人日均药品费用以及上述目标药品比例确定待监控医疗单位的药品费用是否超标的具体实现方式可参见上述实施例中步骤S15所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，针对不同医疗单位进行用药监控时，还可基于各个医疗单位的 单位属性信息确定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，上述考核指标阈值可包括日均药品费用阈值、人日均药品费用阈值以及贵重药品比例阈值等多个用药指标的达标上限，例如日均药品费用的达标上限等。为方便描述，上述多个用药指标的达标上限将以日均药品费用的达标上限为例进行说明，即日均药品费用阈值。其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种，具体可根据实际应用场景确定，在此不做限制。例如，基于不同地域、不同城市、不同药品供应渠道或者不同病患流动量等参数所关联的不同医疗单位，用药监控的考核指标阈值可不尽相同，即不同医疗单位对应的日均药品费用阈值可不尽相同。例如，对于物价较高的城市所关联的医疗单位或者药品供应渠道所带来的药品成本价较高所关联的医疗单位，则可将其日均药品费用的达标上限可设置得较高一些，即其对应的日均药品费用阈值则可设定为较高的阈值等。对于物价较低的城市所关联的医疗单位或者药品供应渠道所带来的药品成本价较低所关联的医疗单位，则可将其日均药品费用的达标上限可设置得较低一些，即其对应的日均药品费用阈值则可设定为较低的阈值等。具体可根据实际应用场景确定，在此不做限制。同理，对应待监控医疗单位的人日均药品费用阈值以及贵重药品比例阈值的设定也可采用与日均药品费用阈值的设定方式，具体可根据实际应用场景确定，在此不做限制。
在一些可行的实施方式中，对待监控医疗单位进行用药监控时，可基于待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数进行综合评价。若上述待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例这三个用药指标参数中有一个以及一个以上用药指标参数大于其对应的用药指标参数阈值，则可确定待监控医疗单位的药品费用超标，否则确定待监控医疗单位的药品费用不超标。具体可参见上述实施例中步骤S15所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，若上述日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数中有两个或者两个以上的用药指标参数超标，则可基于大数据分析寻找得到各个用药指标参数的超标原因。例如，利用大数据分析确定出各个医疗单位的用药指标参数中超标项用药指标参数对应的药品详情，进而可基于各个医疗单位的超标项用药指标参数的药品详情确定出各项用药指标参数的超标原因，以根据各项用药指标参数的超标原因进行药品费用管控。此外，在上述日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数中有两个或者两个以上超标时，可从上述多个用药指标参数中确定出用药指标参数值最大的最大用药指标参数。例如，若待监控医疗单位的日均药品费用、人日均药品费用以及贵重药品比例等多个用药指标参数中有两个或者两个以上的用药指标参数超标，此时日均药品费用是X1元、人日均药品费用是X2元、贵重药品比例超标所对应的贵重药品费用是X3元。其中，若上述X1大于X2，X2大于X3，则此时上述日均药品费用、人日均药品费用和贵重药品比例的三个用药指标参数中用药指标参数最大的是日均药品费用。
在一些可行的实施方式中，在上述日均药品费用、人日均药品费用和贵重药品比例的三个用药指标参数中用药指标参数最大的是日均药品费用时，在可基于大数据分析确定出日均药品费用超标的原因，例如某一个药品(为方便描述可以超标药品为例进行说明)的费用导致的超标等，进而可该超标药品的费用作为待监控医疗单位的药品费用的控费标准。此时，可将上述X1元作为待监控医疗单位的药品费用的基准，进而可将上述X2元中包含的上述超标药品所关联的药品费用剔除得到不包括上述超标药品的药品费用之外的人日均药品费用X2’。同理，可将上述X3元中包含的上述超标药品所关联的药品费用剔除得到不包括上述超标药品的药品费用的贵重药品费用X3’，并根据剔除了超标药品的药品费用之后的贵重药品费用确定剔除超标药品之后的贵重药品比例。上述两个或者两个以上的用药指标参数中去除用药指标参数最大的日均药品费用之后，可进一步判断剔除超标药品之外的人日均药品费用或者贵重药品比例等用药指标参数是否超标，或者上述剔除超标药品的药品费用之外的人日均药品费用或者贵重药品比例等多个用药指标参数对应的药品费用累计计算是否超标。若上述剔除超标药品的药品费用之外的人日均药品费用或者贵重药品比例等多个用药指标参数依然存在一个或者一个以上的用药指标参数超标，即包含日均药品费用的这个最大用药指标参数在内依然是两个或者两个以上用药指标参数超标，或者上述剔除超标药品的药品费用之外的人日均药品费用或者贵重药品比例等多个用药指标参数对应的药品费用累计计算超标，则可确定该医疗单位的药品费用是超标的。若上述剔除超标药品的药品费用之外的人日均药品费用或者贵重药品比例等多个用药指标参数中超标用药指标参数小于一个，或者上述剔除超标药品的药品费用之外的人日均药品费用或者贵重药品比例等多个用药指标参数对应的药品费用累计计算不超标，则可确定该医疗单位的药品费用是达标的。具体可根据实际应用场景确定，在此不做限制。
S27，若上述待监控医疗单位的药品费用超标，则基于日均药品费用、人日均药品费用以及目标药品比例向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
在一些可行的实施方式中，基于日均药品费用、人日均药品费用以及目标药品比例等用药指标参数，输出药品费用超标预警标识至上述待监控医疗单位的医师开方工具首页以向待监控医疗单位的医师发出药品费用超标预警，以及对上述待监控医疗单位超标部分的药品费用差值进行公示，以实现对待监控医疗单位的药品费用超标预警的实现方式可参见上述实施例中步骤S16所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，在针对待监控医疗单位的后期药品费用超标预警的应用场景中，基于上述超标用药指标参数对应的药品费用超标数据，还可在接收到该待监控医疗单位提交的药品费用报销请求或者药品费用理赔请求时，可通过拒绝该待监控医疗单位的药品费用报销请求或者药品费用理赔请求，实现针对该待监控医疗单位的在当前考核周期内药品费用超标的这项考核标准进行惩罚，以对该医疗单位进行后续考核周期的药品费用超标预警。例如，当该医疗单位的某一天的日均药品费用超标时，可在接收到医疗单位提报的该天的药品费用报销和/或请求时，向该医疗单位反馈该天所有处方的药品费用的报销失败。换句话说，当该医疗单位的某一天的日均药品费用超标时，终端设备接收到医疗单位提报的该天的处方药品费用报销和/或理赔请求时，可对该医疗单位反馈该天的处方药品费用拒绝报销或者理赔，进而可提示该医疗单位对每天处方的日均药品费用进行自我把控，防止后续一天或者多天内日均药品费用超标以实现对该医疗单位的药品费用超标的预警。
可选的，在一些可行的实施方式中，当待监控医疗单位的药品费用超标，例如医疗单位单日处方的日均药品费用大于日均药品费用阈值时，终端设备可计算待监控医疗单位的日均药品费用与上述日均药品费用阈值之间的差值(即药品费用超标数据)。当终端设备接收到该待监控医疗单位的药品费用报销和/或理赔请求时，则可针对该待监控医疗单位的日均药品费用与上述人日均药品费用阈值之间的差值，对该待监控医疗单位单日处方的药品费用中差值部分药品费用拒绝报销或者理赔以对该医疗单位进行后续考核周期的药品费用超标预警。
可选的，在一些可行的实施方式中，当终端设备确定待监控医疗单位某一个考核周期(即当前考核周期，例如一天或者一星期等)内的处方的用药超标，例如待监控医疗单位某个考核周期内的处方(例如单日处方)的日均药品费用大于日均药品费用阈值时，终端设备则可在该考核周期(单日处方的日均药品费用超标是某一天，例如周一)之后的下一个考核周期(单日处方的日均药品费用超标这天的第二天，例如周二)的开始时将该考核周期的日均药品费用超标报告通过即时通讯信息、邮件和/或告示中的一种或者多种信息类型发送给该待监控医疗单位。其中，该日均药品费用超标报告用于提示该待监控医疗单位在该考核周期内药品费用超标，并可提醒该待监控医疗单位若在下一个考核周期或者指定时间内的连续多个考核周期内日均药品费用依然超标，则将对该待监控医疗单位进行日均药品费用超标的惩罚的药品费用超标预警。其中，上述惩罚包括对该待监控医疗单位超标的日均药品费用全部拒绝报销或者理赔，或者对该待监控医疗单位的日均药品费用的超标部分拒绝报销或者理赔等。上述日均药品费用超标报告用于提示该待监控医疗单位对日均药品费用进行自我把控以实现对该待监控医疗单位的药品费用控制。
基于本申请实施例提供的方法实现对各医疗单位的用药监控操作方式多样，既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性，进而可提高基于各个医疗单位的用药情况对各个医疗单位的处方进行药品费用超标预警的公示、和/或拒绝药品费用超标对应的药品费用报销和/或理赔请求等药品费用超标预警的可靠性，可提高对待监控医疗单位的药品费用超标预警的时效性，从而可提高医疗资源的有效利用率，适用性更强。
实施例三：
参见图3，图3是本申请实施例提供的基于数据处理的药品费用控制装置的实施例结构示意图。本申请实施例提供的基于数据处理的药品费用控制装置包括：
数据获取单元31，用于获取待监控医疗单位的用药处方，并获取上述用药处方中所包括的药品信息。
药品信息处理单元32，用于根据上述数据获取单元31获取的上述药品信息确定上述待监控医疗单位的日均药品费用。
药品信息处理单元32，还用于根据上述数据获取单元31获取的上述用药处方中包括的病患信息确定上述用药处方所对应的病患数量，根据上述药品信息和上述病患数量确定上述待监控医疗单位的人日 均药品费用。
药品信息处理单元32，还用于根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例。
药品费用监控单元33，用于确定上述药品信息处理单元32确定的上述日均药品费用、上述人日均药品费用以及上述目标药品比例是否大于上述待监控医疗单位的用药指标参数阈值。
药品费用控制单元34，用于在上述药品费用监控单元33确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值时，向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
在一些可行的实施方式中，上述药品费用超标预警信息包括药品费用超标预警标识；
上述药品费用控制单元34用于：
输出药品费用超标预警标识至上述待监控医疗单位的医师开方工具首页，基于上述医师开方工具首页上显示的上述药品费用超标预警标识，向上述待监控医疗单位的医师发出药品费用超标预警，以提示上述待监控医疗单位的医师进行开方用药的药品费用控制。
在一些可行的实施方式中，上述用药处方包括上述待监控医疗单位在当前考核周期内的所有用药处方；
上述药品费用控制单元34用于：
根据上述日均药品费用、上述人日均药品费用、上述目标药品比例以及上述用药指标参数阈值确定上述待监控医疗单位在上述当前考核周期内的药品费用超标数据；
根据上述药品费用超标数据向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位在当前考核周期之后的一个或者多个考核周期内进行开方用药的药品费用控制；
其中，上述药品费用超标预警信息包括即时通讯信息、邮件或者告示中的一种或者多种信息类型。
在一些可行的实施方式中，上述数据获取单元31用于：
获取上述待监控医疗单位的数据系统准入资格，基于上述数据系统准入资格从上述待监控医疗单位的数据系统中获取上述待监控医疗单位的用药处方；和/或
获取上述待监控医疗单位提供的医疗理赔数据，从上述医疗理赔数据中获取上述待监控医疗单位的用药处方；
其中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单个考核周期内的所有用药处方，上述单个考核周期包括单日或者多日。
在一些可行的实施方式中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单日内的所有用药处方；
上述药品信息处理单元32用于：
获取上述所有用药处方中所包括的各药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述各药品的药品金额确定上述所有用药处方所包括的所有药品的药品总额，并根据上述各药品的药品使用天数确定上述所有用药处方的药品使用总天数；
根据上述药品总额和上述药品使用总天数确定上述待监控医疗单位的日均药品费用。
在一些可行的实施方式中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在多日的单个考核周期内的所有用药处方；
上述药品信息处理单元32用于：
获取上述单个考核周期内任一日的任一单日用药处方，并获取上述任一单日用药处方中所包括的各药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述任一单日用药处方所包括的各药品的药品金额和药品使用天数确定上述待监控医疗单位的单日日均药品费用；
根据上述待监控医疗单位在上述单个考核周期内各日的单日日均药品费用和药品使用总天数确定上述待监控医疗单位的日均药品费用；
其中，任一日的药品使用总天数为上述任一单日用药处方中所包括的各药品的药品使用天数的总和。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述单个考核周期内各日的单日日均药品费用确定上述单个考核周期的单日日均药品费用累 加值，根据上述单个考核周期内各日的药品使用总天数确定上述单个考核周期内的药品使用总天数累加值；
根据上述单日日均药品费用累加值和上述药品使用总天数累加值确定上述待监控医疗单位的日均药品费用。
其中，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝单日日均药品费用累加值/药品使用总天数累加值。
可选的，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝周期药品总额/周期药品使用总天数；
其中，在上述周期药品总额可以是单个考核周期内的所有处方的所有药品的药品金额累加得到的所有药品的总金额，上述周期药品使用总天数可以是单个考核周期内的所有药品中每个药品的药品使用天数的累加值。
在一些可行的实施方式中，上述药品信息处理单元32用于：
获取上述用药处方中所包括的病患信息，并根据上述病患信息确定上述用药处方所针对的病患人次，其中，一用药处方针对一病患人次；
将上述病患人次确定为上述用药处方所对应的病患数量。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述药品信息确定上述用药处方中所包括的药品总数和上述待监控医疗单位的日均药品费用；
根据上述日均药品费用、上述病患数量和上述药品总数确定上述待监控医疗单位的人日均药品费用。
其中，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝药品总额/药品使用总天数；
上述待监控医疗单位的人日均药品费用满足：
人日均药品费用＝药品总数/病患数量*日均药品费用。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述药品信息确定出上述用药处方中所包括的各类药品的药品信息，上述各类药品的药品信息中至少包括各类药品的药品金额和药品使用天数；
根据上述各类药品的药品信息确定出上述用药处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数；
根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用；
根据上述各类药品的单药日均药品费用确定出上述用药处方对应的单药日均药品费用阈值，并将上述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的药品确定为上述用药处方中的目标药品。
其中，上述任一类药品的单药日均药品费用满足：
单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述各类药品的药品信息确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述目标药品的目标药品总额；
根据上述所有药品的药品总额和上述目标药品总额确定出上述用药处方的目标药品比例；
其中，上述目标药品比例满足：
目标药品比例＝目标药品总额/所有药品的药品总额。
在一些可行的实施方式中，上述用药指标参数阈值包括日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
上述药品费用监控单元33用于：
根据上述待监控医疗单位的单位属性信息确定上述待监控医疗单位的日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
确定上述日均药品费用是否大于上述日均药品费用阈值；和/或
确定上述人日均药品费用是否大于上述人日均药品费用阈值；和/或
确定上述目标药品比例是否大于上述目标药品比例阈值；
其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药 品供应渠道以及单位病患人次中的一种或多种。
在一些可行的实施方式中，上述基于数据处理的药品费用控制装置可通过其内置的各个功能模块执行如上述图1至图2中各个步骤所提供的实现方式。可选的，上述基于数据处理的药品费用控制装置可为上述各个实施例中所描述的终端设备，在此不做限制。
在本申请实施例中，基于用药监控装置可实现对各医疗单位的用药监控操作方式多样，既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性，进而可提高基于各个医疗单位的用药情况对各个医疗单位的处方进行药品费用超标的公示、和/或拒绝用药指标参数超标对应的药品费用报销和/或理赔请求等用药超标的风险控制的可靠性，可提高该医疗单位开方的用药可控性，从而可提高医疗资源的有效利用率，适用性更强。
实施例四：
参见图4，图4是本申请实施例提供的一种终端设备的实施例结构示意图。如图4所示，本实施例中的终端设备可以包括：一个或多个处理器401、存储器402和一个或者多个收发器403。上述处理器401、存储器402和收发器403通过总线404连接。存储器402用于存储计算机程序，该计算机程序包括程序指令，处理器401和收发器403用于执行存储器402存储的程序指令。其中，上述处理器401被配置用于调用该程序指令执行如下操作：
获取待监控医疗单位的用药处方；
获取上述用药处方中所包括的药品信息，并根据上述药品信息确定上述待监控医疗单位的日均药品费用；
根据上述用药处方中包括的病患信息确定上述用药处方所对应的病患数量，根据上述药品信息和上述病患数量确定上述待监控医疗单位的人日均药品费用；
根据上述药品信息中所包括的各类药品的药品信息确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定上述目标药品在上述用药处方中的目标药品比例；
确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例是否大于上述待监控医疗单位的用药指标参数阈值。
上述收发器403，用于在上述处理器402确定上述日均药品费用、上述人日均药品费用以及上述目标药品比例大于上述待监控医疗单位的用药指标参数阈值，则向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位进行药品费用控制。
在一些可行的实施方式中，上述药品费用超标预警信息包括药品费用超标预警标识；
上述收发器403，用于：
输出药品费用超标预警标识至上述待监控医疗单位的医师开方工具首页，基于上述医师开方工具首页上显示的上述药品费用超标预警标识，向上述待监控医疗单位的医师发出药品费用超标预警，以提示上述待监控医疗单位的医师进行开方用药的药品费用控制。
在一些可行的实施方式中，上述用药处方包括上述待监控医疗单位在当前考核周期内的所有用药处方；
上述收发器403，用于：
根据上述日均药品费用、上述人日均药品费用、上述目标药品比例以及上述用药指标参数阈值确定上述待监控医疗单位在上述当前考核周期内的药品费用超标数据；
根据上述药品费用超标数据向上述待监控医疗单位发送药品费用超标预警信息，基于上述药品费用超标预警信息提示上述待监控医疗单位在当前考核周期之后的一个或者多个考核周期内进行开方用药的药品费用控制；
其中，上述药品费用超标预警信息包括即时通讯信息、邮件或者告示中的一种或者多种信息类型。
在一些可行的实施方式中，上述处理器401，用于：
获取上述待监控医疗单位的数据系统准入资格，基于上述数据系统准入资格从上述待监控医疗单位的数据系统中获取上述待监控医疗单位的用药处方；和/或
获取上述待监控医疗单位提供的医疗理赔数据，从上述医疗理赔数据中获取上述待监控医疗单位的用药处方；
其中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单个考核周期内的所有用药处方，上述单个考核周期包括单日或者多日。
在一些可行的实施方式中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单日内的所 有用药处方；
上述处理器401，用于：
获取上述所有用药处方中所包括的各药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述各药品的药品金额确定上述所有用药处方所包括的所有药品的药品总额，并根据上述各药品的药品使用天数确定上述所有用药处方的药品使用总天数；
根据上述药品总额和上述药品使用总天数确定上述待监控医疗单位的日均药品费用。
在一些可行的实施方式中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在多日的单个考核周期内的所有用药处方；
上述处理器401，用于：
获取上述单个考核周期内任一日的任一单日用药处方，并获取上述任一单日用药处方中所包括的各药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述任一单日用药处方所包括的各药品的药品金额和药品使用天数确定上述待监控医疗单位的单日日均药品费用；
根据上述待监控医疗单位在上述单个考核周期内各日的单日日均药品费用和药品使用总天数确定上述待监控医疗单位的日均药品费用；
其中，任一日的药品使用总天数为上述任一单日用药处方中所包括的各药品的药品使用天数的总和。
在一些可行的实施方式中，上述处理器401，用于：
根据上述单个考核周期内各日的单日日均药品费用确定上述单个考核周期的单日日均药品费用累加值，根据上述单个考核周期内各日的药品使用总天数确定上述单个考核周期内的药品使用总天数累加值；
根据上述单日日均药品费用累加值和上述药品使用总天数累加值确定上述待监控医疗单位的日均药品费用。
其中，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝单日日均药品费用累加值/药品使用总天数累加值。
可选的，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝周期药品总额/周期药品使用总天数；
其中，在上述周期药品总额可以是单个考核周期内的所有处方的所有药品的药品金额累加得到的所有药品的总金额，上述周期药品使用总天数可以是单个考核周期内的所有药品中每个药品的药品使用天数的累加值。
在一些可行的实施方式中，上述处理器401，用于：
获取上述用药处方中所包括的病患信息，并根据上述病患信息确定上述用药处方所针对的病患人次，其中，一用药处方针对一病患人次；
将上述病患人次确定为上述用药处方所对应的病患数量。
在一些可行的实施方式中，上述处理器401，用于：
根据上述药品信息确定上述用药处方中所包括的药品总数和上述待监控医疗单位的日均药品费用；
根据上述日均药品费用、上述病患数量和上述药品总数确定上述待监控医疗单位的人日均药品费用。
其中，上述待监控医疗单位的日均药品费用满足：
日均药品费用＝药品总额/药品使用总天数；
上述待监控医疗单位的人日均药品费用满足：
人日均药品费用＝药品总数/病患数量*日均药品费用。
在一些可行的实施方式中，上述处理器401，用于：
根据上述药品信息确定出上述用药处方中所包括的各类药品的药品信息，上述各类药品的药品信息中至少包括各类药品的药品金额和药品使用天数；
根据上述各类药品的药品信息确定出上述用药处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数；
根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用；
根据上述各类药品的单药日均药品费用确定出上述用药处方对应的单药日均药品费用阈值，并将上 述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的药品确定为上述用药处方中的目标药品。
其中，上述任一类药品的单药日均药品费用满足：
单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
在一些可行的实施方式中，上述处理器401，用于：
根据上述各类药品的药品信息确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述目标药品的目标药品总额；
根据上述所有药品的药品总额和上述目标药品总额确定出上述用药处方的目标药品比例；
其中，上述目标药品比例满足：
目标药品比例＝目标药品总额/所有药品的药品总额。
在一些可行的实施方式中，上述用药指标参数阈值包括日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
上述处理器401，用于：
根据上述待监控医疗单位的单位属性信息确定上述待监控医疗单位的日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
确定上述日均药品费用是否大于上述日均药品费用阈值；和/或
确定上述人日均药品费用是否大于上述人日均药品费用阈值；和/或
确定上述目标药品比例是否大于上述目标药品比例阈值；
其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
在一些可行的实施方式中，上述处理器401可以是中央处理单元(central processing unit，CPU)，该处理器还可以是其他通用处理器、数字信号处理器(digital signal processor，DSP)、专用集成电路(application specific integrated circuit，ASIC)、现成可编程门阵列(field-programmable gate array，FPGA)或者其他可编程逻辑器件、分立门或者晶体管逻辑器件、分立硬件组件等。通用处理器可以是微处理器或者该处理器也可以是任何常规的处理器等。
该存储器402可以包括只读存储器和随机存取存储器，并向处理器401和收发器403提供指令和数据。存储器402的一部分还可以包括非易失性随机存取存储器。例如，存储器402还可以存储设备类型的信息。
在一些可行的实施方式中，上述终端设备可通过其内置的处理器401和收发器403的各个功能模块执行如上述图1至图2中各个步骤所提供的实现方式，具体可参见上述各个步骤所提供的实现方式，在此不再赘述。
基于本申请实施例提供的终端设备可实现对各医疗单位的用药监控操作方式多样，既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性。进而可提高终端设备基于各个医疗单位的用药情况对各个医疗单位的处方进行药品费用超标预警的公示、和/或拒绝药品费用超标对应的药品费用报销和/或理赔请求等药品费用超标预警的可靠性，可提高对待监控医疗单位的药品费用超标预警的时效性，从而可提高医疗资源的有效利用率，适用性更强。
本申请实施例还提供一种计算机可读存储介质，该计算机可读存储介质存储有计算机程序，该计算机程序包括程序指令，该程序指令被处理器执行时实现图1至图2中各个步骤所提供的基于数据处理的药品费用控制方法，具体可参见上述各个步骤所提供的实现方式，在此不再赘述。
上述计算机可读存储介质可以是前述任一实施例提供的基于数据处理的药品费用控制装置或者上述终端设备的内部存储单元，例如电子设备的硬盘或内存。该计算机可读存储介质也可以是该电子设备的外部存储设备，例如该电子设备上配备的插接式硬盘，智能存储卡(smart media card,SMC)，安全数字(secure digital,SD)卡，闪存卡(flash card)等。
以上所述，仅为本申请的具体实施方式，但本申请的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本申请揭露的技术范围内，可轻易想到变化或替换，都应涵盖在本申请的保护范围之内。因此，本申请的保护范围应以所述权利要求的保护范围为准。

Claims (20)

  1. 一种基于数据处理的药品费用控制方法，其特征在于，所述方法包括：
    获取待监控医疗单位的用药处方；
    获取所述用药处方中所包括的药品信息，并根据所述药品信息确定所述待监控医疗单位的日均药品费用；
    根据所述用药处方中包括的病患信息确定所述用药处方所对应的病患数量，根据所述药品信息和所述病患数量确定所述待监控医疗单位的人日均药品费用；
    根据所述药品信息中所包括的各类药品的药品信息确定出所述用药处方中的目标药品，并根据所述各类药品的药品信息确定所述目标药品在所述用药处方中的目标药品比例；
    确定所述日均药品费用、所述人日均药品费用以及所述目标药品比例是否大于所述待监控医疗单位的用药指标参数阈值；
    若所述日均药品费用、所述人日均药品费用以及所述目标药品比例大于所述待监控医疗单位的用药指标参数阈值，则向所述待监控医疗单位发送药品费用超标预警信息，基于所述药品费用超标预警信息提示所述待监控医疗单位进行药品费用控制。
  2. 根据权利要求1所述的方法，其特征在于，所述药品费用超标预警信息包括药品费用超标预警标识；
    所述向所述待监控医疗单位发送药品费用超标预警信息包括：
    输出药品费用超标预警标识至所述待监控医疗单位的医师开方工具首页，基于所述医师开方工具首页上显示的所述药品费用超标预警标识，向所述待监控医疗单位的医师发出药品费用超标预警，以提示所述待监控医疗单位的医师进行开方用药的药品费用控制。
  3. 根据权利要求1所述的方法，其特征在于，所述用药处方包括所述待监控医疗单位在当前考核周期内的所有用药处方；
    所述向所述待监控医疗单位发送药品费用超标预警信息，基于所述药品费用超标预警信息提示所述待监控医疗单位进行药品费用控制包括：
    根据所述日均药品费用、所述人日均药品费用、所述目标药品比例以及所述用药指标参数阈值确定所述待监控医疗单位在所述当前考核周期内的药品费用超标数据；
    根据所述药品费用超标数据向所述待监控医疗单位发送药品费用超标预警信息，基于所述药品费用超标预警信息提示所述待监控医疗单位在当前考核周期之后的一个或者多个考核周期内进行开方用药的药品费用控制；
    其中，所述药品费用超标预警信息包括即时通讯信息、邮件或者告示中的一种或者多种信息类型。
  4. 根据权利要求2或3所述的方法，其特征在于，所述获取待监控医疗单位的用药处方包括：
    获取所述待监控医疗单位的数据系统准入资格，基于所述数据系统准入资格从所述待监控医疗单位的数据系统中获取所述待监控医疗单位的用药处方；和/或
    获取所述待监控医疗单位提供的医疗理赔数据，从所述医疗理赔数据中获取所述待监控医疗单位的用药处方；
    其中，所述待监控医疗单位的用药处方包括所述待监控医疗单位在单个考核周期内的所有用药处方，所述单个考核周期的周期时长包括单日或者多日。
  5. 根据权利要求4所述的方法，其特征在于，所述待监控医疗单位的用药处方包括所述待监控医疗单位在单日内的所有用药处方；
    所述获取所述用药处方中所包括的药品信息，并根据所述药品信息确定所述待监控医疗单位的日均药品费用包括：
    获取所述所有用药处方中所包括的各药品的药品信息，所述药品信息中至少包括药品金额和药品使用天数；
    根据所述各药品的药品金额确定所述所有用药处方所包括的所有药品的药品总额，并根据所述各药品的药品使用天数确定所述所有用药处方的药品使用总天数；
    根据所述药品总额和所述药品使用总天数确定所述待监控医疗单位的日均药品费用。
  6. 根据权利要求4所述的方法，其特征在于，所述待监控医疗单位的用药处方包括所述待监控医疗单位在多日的单个考核周期内的所有用药处方；
    所述获取所述用药处方中所包括的药品信息，并根据所述药品信息确定所述待监控医疗单位的日均药品费用包括：
    获取所述单个考核周期内任一日的任一单日用药处方，并获取所述任一单日用药处方中所包括的各药品的药品信息，所述药品信息中至少包括药品金额和药品使用天数；
    根据所述任一单日用药处方所包括的各药品的药品金额和药品使用天数确定所述待监控医疗单位的单日日均药品费用；
    根据所述待监控医疗单位在所述单个考核周期内各日的单日日均药品费用和药品使用总天数确定所述待监控医疗单位的日均药品费用；
    其中，任一日的药品使用总天数为所述任一单日用药处方中所包括的各药品的药品使用天数的总和。
  7. 根据权利要求6所述的方法，其特征在于，所述根据所述待监控医疗单位在所述单个考核周期内各日的单日日均药品费用和药品使用总天数确定所述待监控医疗单位的日均药品费用包括：
    根据所述单个考核周期内各日的单日日均药品费用确定所述单个考核周期的单日日均药品费用累加值，根据所述单个考核周期内各日的药品使用总天数确定所述单个考核周期内的药品使用总天数累加值；
    根据所述单日日均药品费用累加值和所述药品使用总天数累加值确定所述待监控医疗单位的日均药品费用。
  8. 根据权利要求5或6所述的方法，其特征在于，所述根据所述用药处方中包括的病患信息确定所述用药处方所对应的病患数量包括：
    获取所述用药处方中所包括的病患信息，并根据所述病患信息确定所述用药处方所针对的病患人次，其中，一用药处方针对一病患人次；
    将所述病患人次确定为所述用药处方所对应的病患数量。
  9. 根据权利要求8所述的方法，其特征在于，所述根据所述药品信息和所述病患数量确定所述待监控医疗单位的人日均药品费用包括：
    根据所述药品信息确定所述用药处方中所包括的药品总数和所述待监控医疗单位的日均药品费用；
    根据所述日均药品费用、所述病患数量和所述药品总数确定所述待监控医疗单位的人日均药品费用。
  10. 根据权利要求4所述的方法，其特征在于，所述根据所述药品信息中所包括的各类药品的药品信息确定出所述用药处方中的目标药品包括：
    根据所述药品信息确定出所述用药处方中所包括的各类药品的药品信息，所述各类药品的药品信息中至少包括各类药品的药品金额和药品使用天数；
    根据所述各类药品的药品信息确定出所述用药处方中任一类药品的药品总额以及所述任一类药品的药品使用总天数；
    根据所述任一类药品的药品总额和所述任一类药品的药品使用总天数确定所述任一类药品的单药日均药品费用以得到所述各类药品的单药日均药品费用；
    根据所述各类药品的单药日均药品费用确定出所述用药处方对应的单药日均药品费用阈值，并将所述各类药品中单药日均药品费用大于或者等于所述单药日均药品费用阈值的药品确定为所述用药处方中的目标药品。
  11. 根据权利要求10所述的方法，其特征在于，所述根据所述各类药品的药品信息确定出所述目标药品在所述用药处方的目标药品比例包括：
    根据所述各类药品的药品信息确定出所述用药处方中所有药品的药品总额，以及所述用药处方中所包括的所述目标药品的目标药品总额；
    根据所述所有药品的药品总额和所述目标药品总额确定出所述用药处方的目标药品比例；
    其中，所述目标药品比例满足：
    目标药品比例＝目标药品总额/所有药品的药品总额。
  12. 根据权利要求1-11任一项所述的方法，其特征在于，所述用药指标参数阈值包括日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
    所述确定所述日均药品费用、所述人日均药品费用以及所述目标药品比例是否大于所述待监控医疗单位的用药指标参数阈值包括：
    根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
    确定所述日均药品费用是否大于所述日均药品费用阈值；和/或
    确定所述人日均药品费用是否大于所述人日均药品费用阈值；和/或
    确定所述目标药品比例是否大于所述目标药品比例阈值；
    其中，所述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
  13. 一种基于数据处理的药品费用控制装置，其特征在于，所述装置包括：
    数据获取单元，用于获取待监控医疗单位的用药处方，并获取所述用药处方中所包括的药品信息；
    药品信息处理单元，用于根据所述数据获取单元获取的所述药品信息确定所述待监控医疗单位的日均药品费用；
    药品信息处理单元，还用于根据所述数据获取单元获取的所述用药处方中包括的病患信息确定所述用药处方所对应的病患数量，根据所述药品信息和所述病患数量确定所述待监控医疗单位的人日均药品费用；
    药品信息处理单元，还用于根据所述药品信息中所包括的各类药品的药品信息确定出所述用药处方中的目标药品，并根据所述各类药品的药品信息确定所述目标药品在所述用药处方中的目标药品比例；
    药品费用监控单元，用于确定所述药品信息处理单元确定的所述日均药品费用、所述人日均药品费用以及所述目标药品比例是否大于所述待监控医疗单位的用药指标参数阈值；
    药品费用控制单元，用于在所述药品费用监控单元确定所述日均药品费用、所述人日均药品费用以及所述目标药品比例大于所述待监控医疗单位的用药指标参数阈值时，向所述待监控医疗单位发送药品费用超标预警信息，基于所述药品费用超标预警信息提示所述待监控医疗单位进行药品费用控制。
  14. 根据权利要求13所述的装置，其特征在于，所述药品信息处理单元用于：
    获取所述用药处方中所包括的病患信息，并根据所述病患信息确定所述用药处方所针对的病患人次，其中，一用药处方针对一病患人次；
    将所述病患人次确定为所述用药处方所对应的病患数量。
  15. 根据权利要求14所述的装置，其特征在于，所述药品信息处理单元用于：
    根据所述药品信息确定所述用药处方中所包括的药品总数和所述待监控医疗单位的日均药品费用；
    根据所述日均药品费用、所述病患数量和所述药品总数确定所述待监控医疗单位的人日均药品费用。
  16. 根据权利要求13所述的装置，其特征在于，所述药品信息处理单元用于：
    根据所述药品信息确定出所述用药处方中所包括的各类药品的药品信息，所述各类药品的药品信息中至少包括各类药品的药品金额和药品使用天数；
    根据所述各类药品的药品信息确定出所述用药处方中任一类药品的药品总额以及所述任一类药品的药品使用总天数；
    根据所述任一类药品的药品总额和所述任一类药品的药品使用总天数确定所述任一类药品的单药日均药品费用以得到所述各类药品的单药日均药品费用；
    根据所述各类药品的单药日均药品费用确定出所述用药处方对应的单药日均药品费用阈值，并将所述各类药品中单药日均药品费用大于或者等于所述单药日均药品费用阈值的药品确定为所述用药处方中的目标药品。
  17. 根据权利要求16所述的装置，其特征在于，所述药品信息处理单元用于：
    根据所述各类药品的药品信息确定出所述用药处方中所有药品的药品总额，以及所述用药处方中所包括的所述目标药品的目标药品总额；
    根据所述所有药品的药品总额和所述目标药品总额确定出所述用药处方的目标药品比例；
    其中，所述目标药品比例满足：
    目标药品比例＝目标药品总额/所有药品的药品总额。
  18. 根据权利要求13-17任一项所述的装置，其特征在于，所述用药指标参数阈值包括日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
    所述药品费用监控单元用于：
    根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的日均药品费用阈值和/或人日均药品费用阈值和/或目标药品比例阈值；
    确定所述日均药品费用是否大于所述日均药品费用阈值；和/或
    确定所述人日均药品费用是否大于所述人日均药品费用阈值；和/或
    确定所述目标药品比例是否大于所述目标药品比例阈值；
    其中，所述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
  19. 一种终端设备，其特征在于，包括处理器、收发器和存储器，所述处理器、所述收发器和所述存储器相互连接，其中，所述存储器用于存储计算机程序，所述计算机程序包括程序指令，所述处理器和所述收发器被配置用于调用所述程序指令，执行如权利要求1-12任一项所述的方法。
  20. 一种计算机可读存储介质，其特征在于，所述计算机可读存储介质存储有计算机程序，所述计算机程序被处理器执行以实现权利要求1-12任一项所述的方法。
PCT/CN2019/094994 2018-10-22 2019-07-08 基于数据处理的药品费用控制方法及装置 WO2020082783A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811232900.3 2018-10-22
CN201811232900.3A CN109545307A (zh) 2018-10-22 2018-10-22 基于数据处理的药品费用控制方法及装置

Publications (1)

Publication Number Publication Date
WO2020082783A1 true WO2020082783A1 (zh) 2020-04-30

Family

ID=65844255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/094994 WO2020082783A1 (zh) 2018-10-22 2019-07-08 基于数据处理的药品费用控制方法及装置

Country Status (2)

Country Link
CN (1) CN109545307A (zh)
WO (1) WO2020082783A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109524079A (zh) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 基于数据处理的药品费用风险控制方法及装置
CN109545307A (zh) * 2018-10-22 2019-03-29 平安医疗健康管理股份有限公司 基于数据处理的药品费用控制方法及装置

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060080139A1 (en) * 2004-10-08 2006-04-13 Woodhaven Health Services Preadmission health care cost and reimbursement estimation tool
CN103985075A (zh) * 2014-05-30 2014-08-13 厦门市智业软件工程有限公司 一种医院成本的分摊方法
CN108172302A (zh) * 2017-12-15 2018-06-15 广州市康软信息科技有限公司 合理用药信息监测方法及系统
CN109545307A (zh) * 2018-10-22 2019-03-29 平安医疗健康管理股份有限公司 基于数据处理的药品费用控制方法及装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060080139A1 (en) * 2004-10-08 2006-04-13 Woodhaven Health Services Preadmission health care cost and reimbursement estimation tool
CN103985075A (zh) * 2014-05-30 2014-08-13 厦门市智业软件工程有限公司 一种医院成本的分摊方法
CN108172302A (zh) * 2017-12-15 2018-06-15 广州市康软信息科技有限公司 合理用药信息监测方法及系统
CN109545307A (zh) * 2018-10-22 2019-03-29 平安医疗健康管理股份有限公司 基于数据处理的药品费用控制方法及装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
程苏华 (CHENG, SUHUA): "智能审核系统在门诊费用管理中的应用 (Application of Intelligent Audit System in Outpatient Expenses Management)", 医院管理论坛 (HOSPITAL MANAGEMENT FORUM), vol. 33, no. 3, 31 March 2016 (2016-03-31), pages 19 - 21 *

Also Published As

Publication number Publication date
CN109545307A (zh) 2019-03-29

Similar Documents

Publication Publication Date Title
US10777059B2 (en) Alert management utilizing mobile devices
WO2020082797A1 (zh) 基于数据处理的药品费用超标预警方法及装置
Tariq et al. Medication dispensing errors and prevention
US20190237174A1 (en) System for gap in care alerts
JP6495300B2 (ja) 介入およびタスク決定を使用する処置のシステムおよび方法
US20100185456A1 (en) Medication management system
WO2020082786A1 (zh) 基于数据处理的用药监控方法及装置
US20190074077A1 (en) Prescription management system and method
WO2020082783A1 (zh) 基于数据处理的药品费用控制方法及装置
CN109255721A (zh) 基于费用预测的保险推荐方法、设备、服务器及可读介质
CN109559795B (zh) 基于数据处理的违规处方单的检测方法及相关设备
Macario et al. Analgesia for labor pain: a cost model
WO2020082791A1 (zh) 基于数据处理的药品费用超标的风险控制方法及装置
WO2020082785A1 (zh) 基于数据处理的用药处方风险控制方法及装置
WO2020082805A1 (zh) 基于数据处理的中药处方药品费用控制方法及装置
WO2020082802A1 (zh) 基于数据处理的药品费用风险控制方法及装置
CN109637613B (zh) 基于数据处理的违规处方单的检测方法及相关设备
US20120253842A1 (en) Methods, apparatuses and computer program products for generating aggregated health care summaries
WO2020082792A1 (zh) 基于数据处理的医疗单位用药监控方法及装置
Bhowmick et al. Prescription audit study from a tertiary care private hospital in Kolkata, India
US20210158945A1 (en) Identifying referral patterns between healthcare entities based on billed claims
Zassman et al. Inpatient pain management in sickle cell disease
Klumpp Electronic medical records and quality of cancer care
Yan et al. Impact of hydrocodone rescheduling on dental prescribing of opioids
Okunev et al. Trends in national opioid prescribing for dental procedures among Medicaid patients

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19875224

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19875224

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22.12.2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19875224

Country of ref document: EP

Kind code of ref document: A1